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ABSTRACT 
 
 
The clonality of 840 invasive human Salmonella enterica serotype Typhimurium 
isolates isolated in Gauteng Province during January 2006 to May 2008 was 
investigated. PFGE analysis revealed 38 clusters: three (clusters 3, 5 and 11) were 
primary clusters. Most isolates originated from Hospital 2 and were isolated from 
patients in the age-range of 15-64 years. Ninety-two percent (256/277) of patients 
with known HIV status were HIV-positive. Antibiotic susceptibility testing showed 
the most commonly expressed antibiotic resistance profiles were ACSSuNa (13%; 
90/671) and ACSSuTNa (12%; 82/671). Thirty-five nosocomial isolates were 
identified in 12 clusters, of which most isolates came from two of our three major 
clusters: cluster 3 (31%; 11/35) and cluster 5 (23%; 8/35). In South Africa, 
Salmonella Typhimurium remains an important opportunistic infection of HIV-
positive patients and may circulate as a nosocomial pathogen over prolonged periods 
within the hospital environment. 
 
The study included characterization of 47 Salmonella isolates recovered from a 150 
chicken specimens purchased in Gauteng Province during September 2007 to April 
2008. Salmonella Heidelberg (34%; 16/47) and Salmonella Infantis (34%; 16/47) 
were the most common serotypes isolated from chickens. PFGE analysis showed 
Salmonella Heidelberg and Salmonella Hadar isolates were similar in PFGE profile 
to equivalent human serotypes, indicating that for these two serotypes some chicken 
and human isolates may be related. PFGE analysis and MLVA showed that some 
 4 
chicken and human Salmonella Typhimurium isolates were similar in molecular 
profile, indicating a relationship between these isolates. An epidemiological 
relationship between chicken and human isolates could not be confirmed; however 
results suggest that Salmonella strains with similar molecular profiles circulate in the 
animal and human communities, supporting the suggestion of animal-to-human 
transmission or possibly human-to-animal transmission. Further work is required to 
confirm this theory. 
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CHAPTER 1 
 
Salmonellosis  
 
1.1 Infectious Diseases 
Intestinal infections cause a great deal of morbidity and mortality in the world and 
rank as the third most common infectious disease (WHO, World Health Report, 
2004), particularly amongst human patients belonging to extreme age-ranges 
(Brenner et al., 2000; Ikumapayi et al., 2007) and immunocompromised patients such 
as HIV-infected patients (Bick, 2004). Salmonellae are a common cause of foodborne 
illnesses (Farmer and Kelly, 1991). These organisms are frequently transmitted 
through the food chain and may even be transmitted from person-to-person via the 
faecal-oral route (Hanes, 2003).  
 
1.2 Characteristics of Salmonellae 
In 1880, salmonellae were described for the first time by Eberth (Darwin and Miller, 
1999). Salmonellae are gram-negative bacteria which are usually motile via 
peritrichous flagella. They are aerobic but can be facultatively anaerobic and do not 
form spores (Bopp et al., 1999). Characteristics shared by most of the Salmonella 
species are that they ferment glucose, maltose and mannitol and forms gas and acid; 
cannot ferment lactose, salicin and sucrose; can use citrate as the sole carbon source 
and furthermore, they produce H2S but cannot produce indole (Farmer and Kelly, 
1991; Hanes, 2003). Salmonellae can survive for a long time in soil and water as well 
as other environments with the pH ranging from four to nine and the temperatures 
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ranging from 8°C to 45°C (Hanes, 2003). Salmonellae can be killed through the 
process of milk pasteurization and adequate cooking of food at temperatures of 70°C 
and above (Hanes, 2003).  
 
The bacterial genus Salmonella belongs to the family Enterobacteriaceae (Bopp et al., 
1999). The genus Salmonella is divided into two species: Salmonella enterica and 
Salmonella bongori (Figure 1.1). Salmonella enterica can be further subdivided into 
six subspecies (See figure 1.1) (Brenner et al., 2000). The usual habitat of Salmonella 
enterica subspecies enterica is warm-blooded animals and the common habitat for the 
remaining Salmonella enterica subspecies (II, IIIa, IIIb, IV, VI) as well as Salmonella 
bongori (V) are cold-blooded animals and the natural environment (Brenner et al., 
2000). These species are further classified at a sub-species level into serovars or 
serotypes based on their cell surface antigens (Baron, 1996). O and H surface 
antigens are bacterial surface structures that are used to differentiate between 
different serotypes of salmonellae, according to the Kauffmann-White scheme 
(Popoff et al., 1998; Popoff, 2001; and Keddy et al., 2005). The O antigen defines the 
serogroup and the H antigen defines the serovar (Popoff, 2001). Salmonella enterica 
subspecies enterica is further clinically subdivided into: Salmonella Typhi and non-
typhoidal Salmonella (NTS). S. enterica serotype Enteritidis (Salmonella Enteritidis) 
and S. enterica serotype Typhimurium (Salmonella Typhimurium) are the most 
dominant among the NTS serotypes affecting humans and animals on a global scale 
(Lim et al., 2003, Palmgren et al., 2006, Sheehan and van Oort, 2006). To date, there 
are approximately 1454 serotypes within the S.  enterica subspecies enterica and in 
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total there are over 2400 serotypes of salmonellae that are capable of causing disease 
in humans and animals (Brenner et al., 2000). Salmonellae can be further subtyped 
into different strains. “A strain is a descriptive subdivision of a species” and is 
defined as “an isolate or group of isolates”. These strains can be distinguished from 
other isolates of the same genus and species by phenotypic or genotypic methods 
(Tenover et al., 1995).  
 
1.3 Salmonella disease 
Salmonella infections are a major cause of gastroenteritis (Hanes, 2003). 
Susceptibility to Salmonella infection, onset of infection and severity of 
salmonellosis depends on several of the host’s physiological factors such as the host’s 
age, fitness level and nutritional state etc. Other determining factors are the 
Salmonella serotype and the number of organisms consumed by the host (Darwin and 
Miller, 1999). The average incubation time of gastroenteritis is about six to 72 hours 
after the consumption of food or water which are contaminated with salmonellae. 
Generally an infectious dose of 100-1000 salmonellae are required to initiate an 
infection, however for certain Salmonella serotypes only as little as 15 to 20 cells are 
required (Clark, 2008). These pathogens reside in the host’s gastrointestinal tract 
where they cause gastrointestinal complications (Hanes, 2003). Some studies show 
that the distal part of the small intestine is the primary site of infection in humans 
(Hughes and Galán, 2002). Gastroenteritis usually only lasts for about a week and the 
clinical symptoms of salmonellosis include diarrhoea, abdominal cramps and a fever 
of 38°C to 39°C (Bopp et al., 1999).  
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In immunocompromised patients, salmonellosis may be prolonged and symptoms 
may be more severe (Weinstein, 1998; Wenzel and Edmond, 2001; Hanes, 2003). As 
a result of a compromised immune system, salmonellae may proliferate at a high rate 
and become invasive by breaking through the mucosa of the small bowel and entering 
the blood stream causing bacteraemia. Prolonged illness is often accompanied by 
low-grade fever, bloody diarrhoea and loss of weight (Hanes, 2003).  Previous studies 
showed that children in the age-range of five years and younger living in tropical 
Africa are more susceptible to bacteraemia caused by NTS (Vaagland et al., 2004). 
HIV-positive patients are more predisposed to recurring bacteraemia caused by 
salmonellae compared to immunocompetent patients (Bick, 2004).  
 
Salmonellae can progress to any anatomical site in the human body via the circulating 
blood (Spraycar, 1995) and may cause local infections and produce abscesses 
(Govinden et al., 2008). The most common sites are the lungs, connective tissue, 
joints, long bones and meninges (Kuppermann, 1999; Kramer and Shapiro, 1997). 
Meningitis caused by salmonellae are a common local infection seen in infants 
(Vaagland et al., 2004). In addition, immunosuppressed patients, who do not receive 
treatment (Kuppermann, 1999; Kramer and Shapiro, 1997), have a 5% to 10% chance 
of bacteraemia progressing into local and systemic infections (Peques et al., 2005). 
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1.4 Diagnosis 
Diagnosis of foodborne diseases is made by the isolation of the infecting organism 
from suspected food and patient stool samples during the acute phase of 
salmonellosis (Hanes, 2003). The detection of salmonellae in stool cultures is time 
consuming and often medical practitioners have to treat patients based on their 
symptoms (Owen and Warren, 2008). Little or no Salmonellae can be isolated from 
stool cultures after about a week of salmonellosis and antibiotic treatment, however 
laboratory findings have shown that salmonellae carriers test positive for these 
causative organisms in stool cultures months after being infected (Hanes, 2003; 
Chambers et al., 2008). Most commonly patients in the age-range of five years and 
younger are reported to be asymptomatic carriers of salmonellae for longer periods 
than older patients (Buchwald and Blaser, 1984). Patients become chronic carriers of 
salmonellae if the infecting organism colonizes the gall bladder (Hanes, 2003). 
Chronic carriers of salmonellae however do not suffer with the symptoms of 
salmonellosis (Owen and Warren, 2008).  
 
In addition to the culture sensitivity tests, PCR evaluation can also be performed to 
detect Salmonella species (Owen and Warren, 2008). Primer sets which are specific 
for Salmonella species are selected (Malorny et al., 2003). PCR is performed on 
sample DNA using these primer sets (Malorny et al., 2003). Amplified DNA is 
electrophoresed in an agarose gel containing ethidium bromide, after which DNA 
fragments in the gel are visualized under UV light (Rahn et al., 1992; Malorny et al., 
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2003; Malorny et al., 2004). The sensitivity of PCR tests on blood, urine and faeces 
are 85%, 69% and 47%, respectively (Hatta and Smits, 2007). 
 
1.5 Isolation and identification 
1.5.1 Preenrichment 
The test sample is put into a preenrichment broth which allows almost all of the 
microorganisms present in the test sample to grow. Peptone water, mannitol purple 
sugar broth as well as lactose and brilliant green are examples of preenrichment 
broths (Hanes, 2003). 
 
1.5.2 Enrichment 
This step is performed to provide a favourable environment for the infective organism 
of interest to grow while suppressing the growth of other microorganisms present in 
the test sample. Examples of selective enrichment broths which are specific for 
enhancing the growth of salmonellae are selenite cystine (SC) broth and Rappaport 
Vassiliadis (RV) broth (Hanes, 2003). This step is followed by plating out some of 
the test sample from the selective broth onto highly differential media. For 
Salmonella species, MacConkey (MAC) agar, Deoxycholate (DCA) agar and Xylose-
lysine-deoxycholate (XLD) agar are commonly used.  Thereafter a series of 
biochemical tests are performed on all suspected Salmonella colonies (Hanes, 2003). 
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1.5.3 Biochemical identification 
Biochemical tests include fermentation of glucose, lysine decarboxylation, ornithine 
decarboxylation, dulcite fermentation, H2S production, motility, indole, mannitol and 
inability for the organism to ferment sucrose or lactose (Table 1.1).  
 
1.6 Serotyping 
O and H surface antigens are bacterial surface structures that are used to differentiate 
between different serotypes of salmonellae, according to the Kauffmann-White 
scheme (Popoff, 2001). The O antigen defines the serogroup and the H antigen 
defines the serotype (Tenover et al., 1995). Salmonella Typhi also has a virulence 
(Vi) or capsular antigen (Popoff, 2001; Koneman, 2006). Salmonellae O, H and Vi 
antibodies are commercially available for Salmonella serotyping (Hanes, 2003). 
Salmonella serotyping is performed by first determining the O phase (Popoff, 2001; 
Hanes, 2003; Koneman, 2006) which is then followed by determining the H phase. 
Many Salmonella species contain more than one H phase and sometimes may only 
express one of the H phases. This is overcome by blocking the recognised H phase 
for that O phase with the H monovalent antibody, which then allows the organism to 
express the other H phase or H phases (Popoff, 2001; Koneman, 2006). Salmonella 
serotypes in S. enterica subspecies enterica (I) are identified and named according to 
the O and H antigens expressed on their bacterial surfaces, whereas unnamed 
Salmonella serotypes in S. enterica subspecies salamae (II) through S. enterica 
subspecies indica (VI) are identified by their antigenic formula (Brenner et al., 2000).  
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1.7 Molecular epidemiology 
Pulsed-field gel electrophoresis (PFGE) (Baggesen et al., 2000), multiple-locus 
variable-number tandem-repeats analysis (MLVA) (Lindstedt et al., 2003), multiple-
locus sequence typing (MLST) (Fakhr et al., 2005) and DNA miccroarrays (Boyd et 
al., 2001) are a few common techniques used to characterize salmonellae at a 
molecular level (Pelludat et al., 2005).  
 
PFGE is a molecular technique which is used to characterize and determine strain 
relatedness among bacterial isolates. In contrast to conventional gel electrophoresis, 
PFGE is able to separate large DNA fragments greater than 50000 base pairs (bp) as a 
result of periodic changes in the direction of the electric field during electrophoresis. 
To execute this method, bacterial cells are first immobilized in agarose plugs for 
protection against any accidental breakage of genomic DNA during this procedure. 
This is followed by the lysis step. Agarose plugs which contain bacterial genomic 
DNA are incubated in lysis buffer containing proteinase-K, N-lauroylsarcosine 
sodium salt and ethylenediaminetetra-acetic acid (EDTA) to release and protect 
genomic DNA. A slice of the agarose plug is then put into a solution containing 
restriction enzyme which digests genomic DNA into several large fragments. The 
number of fragments produced depends on the restriction enzyme chosen for 
digestion. Following the digestion step, agarose slices are placed on a comb and set in 
an agarose of 0.8% gel. The agarose gel is then subjected to PFGE which allows for 
the separation of large DNA fragments. Periodic changes in the direction of the 
electric field during electrophoresis allows DNA molecules to enter and move 
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through the pores of the agarose matrix in a snake-like fashion to produce fingerprint 
patterns. Fingerprint patterns generated by PFGE analysis is visualized using UV 
light after staining the agarose gel with ethidium bromide (Tenover et al., 1995; 
Gautom, 1997). PFGE analysis is the “gold standard” for the subtyping of 
salmonellae. Fakhr and colleagues (Fakhr et al., 2005) revealed that compared to 
MLST, PFGE analysis has a high discriminatory power for the subtyping of 
Salmonella Typhimurium (Fakhr et al., 2005). Another study done by Weill and co-
workers on approximately 4000 S. enterica serotype Typhimurium phage type DT104 
(Salmonella Typhimurium DT104) isolates showed a high incidence of PFGE 
profiles X1. However, another method is required for discriminatory subtyping of 
such isolates (Weill et al., 2006). Research done by Torpdahl and co-workers showed 
that even though PFGE analysis is the standard method for the subtyping of 
salmonellae, it sometimes fails to differentiate between certain related and unrelated 
strains and within definite phage types due to the lack of discriminatory abilities 
(Torpdahl et al., 2006). 
 
Variable number tandem repeats (VNTR’s) are DNA motif repeats found in the 
genome sequence. These DNA motif repeats fall into different classes. The ‘direct 
class repeats’ are called minisatellites, which can contain genetic polymorphisms. 
Minisatellites are found in pathogenic bacteria and humans. Minisatellites are 
‘hypermutable’. Hypermutations occur during DNA replication as a result of slipped 
strand mispairing. Since VNTR’s play a role in the expression of genes and often the 
coding of surface exposed proteins, mutations in the DNA sequence result in changes 
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in the mechanism of function and proteins made. Due to these changes, the host’s 
immune system finds it difficult to recognize bacteria. This enables bacteria to 
multiply rapidly and have a high survival rate in the host (Lindstedt et al., 2005). 
VNTR analysis also known as MLVA is used to screen genomic DNA for repeat 
motifs. MLVA is applied by screening approximately three to eight VNTR loci. 
Specific PCR primer pairs are used to amplify each locus and usually, all primer pairs 
are multiplexed into a single PCR. PCR products are then subjected to electrophoresis 
which separates these PCR products by size to generate DNA fingerprint patterns. 
Unique DNA fingerprint patterns are produced by each individual strain of bacteria. 
MLVA is traditionally performed manually, however due to technological 
advancements over recent years, MLVA has progressively become automated. The 
traditional method of MLVA is carried out by using conventional gel electrophoresis, 
after which DNA fingerprint patterns can be visually examined using UV light. 
Automated MLVA is performed using capillary electrophoresis. This method is 
executed by using primer pairs which are labelled with distinctive fluorescent dyes 
(fluorophores). Each VNTR locus can be labelled with a unique fluorophore; this 
subsequently allows the combination of all primer pairs into a single multiplex-PCR. 
Capillary electrophoresis is performed using a genetic analyzer. PCR products are 
moved past a laser beam which excites fluorophores causing it to emit light of 
distinctive colours. The light is detected and translated into detection of PCR 
products. An internal size standard is used to size PCR products. These sized PCR 
products are reported as a MLVA allele profile (Lindstedt et al., 2004; Torpdahl et 
al., 2007). For example, if five loci were analyzed by MLVA, the MLVA allele 
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profile representing the size of PCR products in base pairs could be reported as ‘160-
248-314-385-525’. MLVA is useful in discriminating within common phage types 
(Torpdahl et al., 2007). Torpdahl et al., (2007) demonstrated in their study that 
MLVA is superior to PFGE analysis for surveillance and outbreak investigations 
(Torpdahl et al., 2007). An earlier study showed that MLVA is a quick, appropriate 
method particularly for outbreak situations and to monitor different phage types 
(Torpdahl et al., 2006). Lindstedt and co-workers used MLVA to show a high level 
of discrimination among 78 strains of Salmonella Typhimurium (Lindstedt et al., 
2003; Lindstedt, 2005). 
       
1.8 Treatment and prevention 
Fluid and electrolyte replacement is necessary for the correction of dehydration 
caused by diarrhoea (Hanes, 2003). Antibiotics are not suggested for uncomplicated 
diarrhoea and chronic carriers. Studies show that antibiotics given to chronic carriers 
prolong the duration of salmonellae excreted in the stool (Sirinavin and Garner, 
2000). Antibiotic therapy is however necessary for immunocompromised patients. 
Different countries address health issues differently: the choice of antibiotic 
treatment, antibiotic usage, dosage and duration of antibiotics recommended to 
patients depend on local antibiotic resistance profiles expressed by salmonellae 
(Yates and Amyes, 2005). Surveillance of salmonellae are routinely conducted in 
several countries worldwide; to detect emerging multidrug-resistant salmonellae that 
may pose a risk to future antibiotic treatment and as a result allows scientists to use 
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this information to make educated decisions about the choice of treatment that can be 
given to patients (Yates and Amyes, 2005).  
 
Nonfoodborne transmission of Salmonella is particularly common among 
slaughterhouse workers, farmers, chefs and veterinarians if exposed to Salmonella 
infected animals. The spread of Salmonella in the above mentioned fields of work can 
be prevented by proper hygienic practice such as adequate hand washing, avoiding 
contact with animal faeces, removal of all soiled work clothes before going indoors as 
well as reducing exposure of soiled work clothes to household members (Hendriksen 
et al., 2004).  
 
Pasteurization of milk and thorough cooking of food at temperatures of 70°C and 
above will greatly reduce foodborne transmission of Salmonella (Hanes, 2003). Post-
contamination of food can be prevented by covering cooked food, thorough hand 
washing, washing of utensils and decontaminating food-preparation areas such as 
table tops with disinfectants (Mosupye and von Holy, 1999). 
 
Typhoid vaccines are available for the prevention of typhoid fever; however there are 
no vaccines available for the prevention of human salmonellosis caused by NTS 
(Mastroeni and Ménager, 2003). 
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1.9 Epidemiology 
Salmonella can be isolated from the intestinal tract of a wide range of hosts which 
include humans, domestic and non-domestic animals (Hanes, 2003). Statistical 
studies show that asymptomatic carriers of Salmonella can spread these causative 
organisms to 0.2% of the common population (Hanes, 2003). Salmonella may be 
transmitted via several routes which include foodborne routes of Salmonella such as 
consumption of food contaminated by Salmonella infected animals or people (Hanes, 
2003); nonfoodborne routes of Salmonella such as direct contact with humans or 
animals infected with Salmonella (Hendriksen et al., 2004); as well as human-to-
human transmission via the faecal-oral route (Hanes, 2003). 
 
Salmonella is most commonly transmitted via foodborne routes (Butaye et al., 2006). 
In the USA, approximately one million people get infected with Salmonella each 
year, of which 95% or more of all the cases are owed to the ingestion of contaminated 
food and water (Butaye et al., 2006; Linam and Gerber, 2007). Water, milk, dairy 
products, beef, poultry, eggs, vegetables and fruit are all common reservoirs for 
Salmonella (Braden, 2006; Linam and Gerber, 2007). Food can be contaminated 
during different stages of preparation. Studies show that about 1% to 50% of the meat 
that is sold at commercial markets is contaminated with Salmonella during the 
slaughtering and processing of food animals (Hanes, 2003). Post-cooking 
contamination is often attributed to poor hygiene practiced by people handling food, 
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the use of contaminated cooking utensils and exposure of cooked food to 
contaminated surface areas and dust containing Salmonella (Mosupye and von Holy, 
1999; Hanes, 2003). 
 
Salmonellae can be carried by various domestic and non-domestic animals and 
exposure to these animals is thus a potential risk factor for human salmonellosis. The 
infection rate of salmonellae in animals fluctuates from less than 1% to greater than 
20% (Hanes, 2003). Salmonella serotypes can be isolated from the gastrointestinal 
tract of approximately 90% of reptiles and amphibians (Linam and Gerber, 2007). 
There is a 6% chance of acquiring an infection via direct contact with reptiles and 
amphibians (Linam and Gerber, 2007). Children are more at risk of getting infected 
with salmonellae from playing with their pet animals such as dogs, cats, turtles and 
snakes etc. (Hanes, 2003). In addition to animal-to-human transmission of 
salmonellae, salmonellae can also be carried by humans and transmitted through 
direct or indirect contact with animals such as pet birds (Anonymous, 2008), zoo 
animals (Jang et al., 2008) and bovine animals (CDC, 2000). 
 
Animal feed produced for domestic and food animals is also frequently contaminated 
with salmonellae at food packing industries (Hanes, 2003). Handling of contaminated 
animal feed or contact with animals who have consumed these contaminated animal 
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feeds, pose a potential risk of Salmonella infection to humans (Hanes, 2003; White et 
al., 2003; Hendriksen et al., 2004). 
 
Person-to-person contact is another route through which salmonellae can be 
transmitted. An example of this is nosocomially acquired infections. Nosocomial 
infections are infections acquired at long-term medical care facilities such as hospitals 
(Edelstein et al., 2004) and nursing homes etc. (Olsen et al., 2001). Hospital acquired 
infections are common in developing countries but are less common in first world 
countries such as in the USA (Olsen et al., 2001). Nosocomial infections are more 
severe in very young patients, immunosuppressed patients and patients receiving a 
cocktail of antibiotics (Olsen et al., 2001).   
 
Reporting inaccuracies are due to underreporting and underdiagnosing of 
salmonellosis and as a result, only a certain fraction of the true number of Salmonella 
cases are reported (Hanes, 2003; Thomas et al., 2006). Large outbreaks of 
salmonellosis tend to draw the attention of health-care professionals and the general 
public and thus are further investigated and reported whereas random cases of 
salmonellosis are often underreported for various reasons (Hanes, 2003). 
Underreporting and underdiagnosing of Salmonella cases is a potential limitation to 
surveillance studies (Thomas et al., 2006). Underreporting makes it difficult to 
evaluate the true trend patterns of Salmonella infections in humans. The following are 
 37 
a few possible reasons as to why a large number of Salmonella cases go 
underreported (Hanes, 2003; Thomas et al., 2006):  
• Outbreaks may be represented by a small number of people with little or no 
severity of illness. This may not alarm health-care professionals or other 
individuals in the community as a public health hazard and as a result may go 
unreported (Hanes, 2003). 
• Health care professionals may not be aware of the outbreak or they may lack 
the motivation to report an outbreak (D’Ortenzio et al., 2008). 
• There may be few or no resources available for conducting active surveillance 
studies due to numerous circumstances (Klovning, 2007).  
• Foodborne outbreaks in cafés and restaurants etc. may also be underreported 
by owners or workers of these eating places, as a scheme to protect the 
reputation of their businesses or jobs, respectively (Klovning, 2007). 
• Unavailability of medical services to Salmonella infected people, such as 
people living in rural areas (Klovning, 2007).  
 
1.10 Pathogenicity 
Salmonellae are transmitted to the host via several routes but most commonly through 
the consumption of contaminated food and water (Butaye et al., 2006; Linam and 
Gerber, 2007). The initiation of infection depends on the Salmonella serotype, the 
number of infecting organisms in the food, the type of food consumed by the host, as 
well as the host’s physiological factors (Owen and Warren, 2008). Some studies show 
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that there should be a large number of infecting organisms to survive the host’s 
gastrointestinal tract’s first line of defence (Darwin and Miller, 1999), which is the 
gastric acid in the stomach and the normal bacterial flora in the small intestine 
(Hanes, 2003; Bick, 2004). The pH of the food consumed also influences 
susceptibility of an individual to infection (Darwin and Miller, 1999; Owen and 
Warren, 2008). For example, if the food consumed has a high pH, it will neutralize 
the gastric acid once it reaches the stomach and will make the individual more 
susceptible to infection (Darwin and Miller, 1999). Reduced peristalsis allows 
salmonellae to flourish in the small intestine and hence prolongs infection (Bick, 
2004). Individuals who have a low immunity, gastric acid with a high pH, decreased 
number of normal bacterial flora in the small bowel and decreased peristalsis (bowel 
movement) are more susceptible to Salmonella infection (Bick, 2004; Owen and 
Warren, 2008). The following are a few examples of individuals who are more 
predisposed to Salmonella infection: 
• Young patients who have immature immune systems and bacterial flora in 
their gastrointestinal tract (Hanes, 2003; Owen and Warren, 2008). 
• Older patients who have declining immune systems and gastric acid with a 
high pH (Hanes, 2003; Owen and Warren, 2008). 
• Patients taking antacids and acid suppression drugs have decreased levels of 
gastric acid in their stomach (Bick, 2004; Owen and Warren, 2008). 
• Patients receiving a cocktail of different types of antibiotic treatment or 
purgatives as well as patients who have undergone bowel surgery have 
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decreased levels of normal bacterial flora in their intestinal tract (Olsen et al., 
2001; Bick, 2004; Owen and Warren, 2008). 
• Patients taking opiate drugs have decreased intestinal movement (Bick, 2004; 
Owen and Warren, 2008).  
 
Once salmonellae have overcome the host’s protective mechanisms such as the 
gastric acid in the stomach and the normal bacterial flora, it then attaches itself to 
intestinal cells via fimbriae or pili (Darwin and Miller, 1999; Hanes, 2003; Owen and 
Warren, 2008). The interaction of salmonellae with the mucosa of the host’s intestinal 
tract has being previously described by using various animal models such as the 
rhesus monkey (Darwin and Miller, 1999), the guinea pig (Takeuchi and Sprinz, 
1967) and mice (Darwin and Miller, 1999; Hanes, 2003). Mice are currently the 
primary choice of animal model for molecular research to enhance our understanding 
on the subject of the interaction of salmonellae with the human intestinal mucosa 
(Darwin and Miller, 1999). Despite various studies that have been carried out using 
different animal models (Francis et al., 1993; Darwin and Miller, 1999; Wallis and 
Galyov, 2000; Mishra et al., 2000; Hanes, 2003; Owen and Warren, 2008), these 
studies are common in their findings that salmonellae first attach to and then invade 
the host’s intestinal mucosa. Invasion of the intestinal mucosa triggers off the host’s 
proinflammatory response to salmonellae and hence causes inflammation of the 
lymph nodes and lamina propria of the intestinal tract (Owen and Warren, 2008). 
Owing to these studies, it is hypothesized that a similar host-pathogen interaction 
occurs when humans get infected with salmonellae (Darwin and Miller, 1999).                                                                                                                                                                                                                                                                     
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Salmonella Typhimurium has four different types of fimbriae called type 1 fimbriae, 
long polar fimbriae, plasmid-encoded fimbriae and thin aggregative fimbriae. 
Fimbriae are associated with adhesion, virulence and may also be associated with 
direct or indirect recruitment of neutrophils (immune cells) (Darwin and Miller, 1999; 
Owen and Warren, 2008). Despite various studies that have been performed on type I 
fimbriae, their function with regards to adhesion and virulence is still poorly 
understood (Darwin and Miller, 1999). Studies performed on a mouse model have 
shown that long polar fimbriae are responsible for the attachment of salmonellae to 
the Peyer’s patches of the small intestine which makes it easier for salmonellae to 
break through the host tissue. Another study which was performed using the small 
intestinal tissue of a mouse model under tissue culture conditions showed that 
plasmid-encoded fimbriae have a high affinity to the host’s villous intestines. Thin 
aggregative fimbriae may be involved in adhesion of salmonellae to the host’s cell 
epithelium however, attachment to specific cell types is not yet known. Thin 
aggregative fimbriae have a propensity to aggregate, hence the name. Scientists 
proposed that this aggregative behaviour increases the chance of salmonellae 
surviving the host’s protective mechanisms such as the gastric acid in the stomach 
(Darwin and Miller, 1999; Owen and Warren, 2008). Studies using mice as animal 
models show that about 25% of salmonellae colonize the Peyer’s patches in the small 
intestine (Darwin and Miller, 1999; Hanes, 2003). Salmonellae initially and most 
exclusively invade mice mucosal M cells and at a later stage invade mice eukaryotic 
cells such as the intestinal absorptive cells (Darwin and Miller, 1999; Hanes, 2003; 
Owen and Warren, 2008). M cells are present in specialized epithelium which covers 
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the Peyer’s patches in the small intestine (Owen and Warren, 2008). M cells play a 
role in gastrointestinal immunity by sampling antigens from the lumen and 
transporting them to antigen presenting cells (Mishra et al., 2000). Once salmonellae 
are attached to the host’s M cells, they send bacterial signals which cause 
cytoskeleton rearrangements in the host’s intestinal cells and hence initiate membrane 
ruffling (Darwin and Miller, 1999; Hanes, 2003). Membrane ruffling of M cells 
causes subsequent pinocytosis of salmonellae (Francis et al., 1993; Hanes, 2003). 
Pinocytosis is the internalization of bacteria by columns of polymerized actin which 
encircle and engulf bacteria (Francis et al., 1993; Wallis and Galyov, 2000; Hanes, 
2003). M cells containing salmonellae then break off from the host’s intestinal 
mucosa, leaving damaged mucosal tissue exposed to the salmonellae in the lumen. 
This allows salmonellae to enter underlying mucosal tissue and the lymphatic system 
(Hanes, 2003).   
   
A number of plasmids are common in the majority of Salmonella serotypes (Hanes, 
2003). Pathogenicity islands can be localized to Salmonella chromosomes or to 
plasmids (Hanes, 2003) and are shown to be responsible for mucosal invasion and 
virulence (Hanes, 2003). Previous studies have identified three systems that are 
localized to the Salmonella Typhimurium chromosome: Salmonella pathogenicity 
island 1 (SPI-1), a system for invasion and virulence; Salmonella pathogenicity island 
2 (SPI-2), a type III secretion system for the survival in macrophages; and a flagellar 
assembly system for motility (Darwin and Miller, 1999). SPI-1 has numerous 
characteristics that are suggestive of horizontal g
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species during its evolution (Wallis and Galyov, 2000; Hanes, 2003). SPI-1, a 40kb 
region, contains over 30 genes which encode for different proteins such as secreted 
effector proteins, regulatory proteins and components of type III secretion system 
(Darwin and Miller, 1999; Hanes, 2003). The gene responsible for invasion (apart 
from the invasion system that is encoded at centisome 63) is the SPI-1 genes, 
invABC(D) (Darwin and Miller, 1999). Salmonellae invasion depend on bacterial 
attachment to the host’s epithelial cell receptors (Wallis and Galyov, 2000). SPI-1 has 
three proteins that play a role in mucosal invasion. These proteins contribute to a 
supramolecular structure which secretes effector proteins and hence send bacterial 
signals to the host’s eukaryotic cells (such as the enterocytes and dendritic cells). 
These signals cause rearrangements of the eukaryotic cytoskeleton which initiates 
membrane ruffling (Darwin and Miller, 1999; Hanes, 2003). The ruffling mechanism 
causes eruption of the host’s cell membrane and subsequent internalization of 
salmonellae (Francis et al., 1993; Hanes, 2003). Salmonellae that overcome the host’s 
immune response will enter into the blood stream from the lymphatic system via the 
thoracic duct and cause bacteraemia (Hanes, 2003).  
 
1.11 Salmonella infections in HIV/AIDS patients 
The lymphoid tissue in the intestinal tract represents about 70% of the human body’s 
immune system (Anitei, 2008). HIV destroys the intestinal immune cells called T 
helper cells which play a role in warning other immune cells in the body regarding 
the site of infection (Anitei, 2008). Studies show that HIV persists and multiplies in 
the tissue macrophages of the reticuloendothelial system in the gut mucosa. HIV 
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causes mass destruction of intestinal immune cells and subsequent decrease in the 
host’s immune response (Gordon et al., 2002; Anitei, 2008). The decrease in the 
host’s immune response allows opportunistic pathogens such as salmonellae to 
invade the intestinal mucosal barrier and enter into the blood stream (Gordon et al., 
2002). In addition, research shows that pathogens are able to survive for a long time 
in monocyte and macrophage type immune cells which further prolong infection in 
HIV-positive patients (Gordon et al., 2002). Disease caused by salmonellae is a 
common opportunistic infection associated with HIV disease (Ikumapayi et al., 
2007). Symptoms include difficulty in swallowing, loss of weight, prolonged 
diarrhoea, low CD4 lymphocyte counts, high incidence of Salmonella bacteraemia 
and Salmonella septicaemia (Bick, 2004). HIV/AIDS patients are about 20 times 
more prone to Salmonella infection and about a 100 times more prone to bacteraemia 
caused by salmonellae than patients with competent immune systems (Fernandez 
Guerrero et al., 1997). Studies also show that about 25% of HIV-positive patients 
with salmonellosis suffer from focal infections (Fernandez Guerrero et al., 1997). 
Salmonellosis may be difficult to diagnose in HIV-infected patients, however if they 
are diagnosed and treated during the early stages of Salmonella infection, this may 
improve their lives considerably (Bick, 2004). Salmonella infections are more likely 
to relapse in HIV/AIDS patients after receiving treatment (Bick, 2004). Recurrent 
salmonellosis is regarded as an AIDS-defining illness (CDC, 1992). Studies show 
that salmonellosis in HIV-positive patients is associated with high morbidity and 
mortality rates (Fernandez Guerrero et al., 1997).   
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According to statistical studies there were about 33 million people worldwide that 
were living with HIV/AIDS at the end of 2007, of which there were two million 
people that died in 2007. Twenty-two million people living with HIV/AIDS were 
from sub-Saharan Africa which represented the majority (67%) of HIV/AIDS 
patients, worldwide (UNAIDS, 2008). Of the remaining HIV/AIDS patients, 15% 
were living in Asia, 6% in North America, Western and Central Europe, 5% in Latin 
America, 5% in Eastern Europe and Central Asia, 1% in North Africa and Middle 
East, 0.7% in Caribbean and 2.0% in Oceania (UNAIDS, 2008). 
 
In North America, about 30% to 70% of HIV-positive patients suffer from diarrhoeal 
diseases (May et al., 1993). An Asian study carried out in the year 2000 by 
Barraclough showed that musculoskeletal infections in HIV-infected patients caused 
by salmonellae were commonly seen in Chinese participants, but were not frequently 
seen in people from Thailand where salmonellosis is common (Barraclough, 2000). 
In Africa, about 90% of HIV/AIDS patients suffer from diarrhoea caused by 
salmonellae and other diarrhoeagenic enteropathogens (Obi et al., 2007). AIDS 
patients in sub-Saharan Africa infected with NTS bacteraemia have a mortality rate of 
35% to 60%. Of the HIV-positive patients who survive, 25% to 45% suffer from 
recurrent NTS bacteraemia about one to six months after the first non-typhoidal 
infection (Kankwatira et al., 2004; Obi et al., 2007). In Blantyre, Malawi, recurrent 
salmonellosis and bacteraemia caused by NTS is common in HIV-infected adults and 
accountable for a high death rate seen amongst many individuals (Gordon et al., 
2002). In Kenya, a study carried out by Gilks et al., (1990) showed that 11% of HIV-
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infected patients suffered from hospital acquired salmonellosis and Salmonella 
bacteraemia. 
 
The burden of HIV disease in South Africa is high (Pembrey, 2008). In South Africa 
in 1998 through to 1999, multidrug-resistant Salmonella Typhimurium DT104 
strains, isolated from HIV-positive patients from the Chris Hani Baragwanath 
Hospital in the Gauteng Province (one of the nine provinces in South Africa) were 
investigated and reported in 2000 by Crewe-Brown and colleagues (Crewe-Brown et 
al., 2000). Annual reports for the years 2006 and 2007 showed that approximately 
1.42 million people in the Gauteng Province of South Africa were infected with HIV 
(ASSA, 2008). 
 
Studies show that Salmonella infections in HIV/AIDS patients are particularly high in 
developing countries such as South Africa especially due to limited potable water and 
poor sanitation in rural areas (Obi et al., 2007). HIV-positive patients living under 
these adverse conditions may be faced with a number of predicaments. For example, 
woman living with HIV/AIDS may deny their infant children breast milk as a 
measure taken to prevent mother-to-child transmission of HIV and they may 
alternatively resort to using untreated water contaminated with salmonellae for the 
preparation of food for their children. This may consequently lead to high morbidity 
and mortality rates among these children as a result of their immature immunity (Obi 
et al., 2007; Dunne et al., 2001).  
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In addition, many people living in the developing countries may not publicize the 
death of their family members or friends out of fear and shame of being discriminated 
and rejected by society (Engelbrecht, 1998). They may consequently resort to secret 
and inappropriate burying of corpses at or near water supply points and as a result 
salmonellae from dead bodies may permeate into water resources increasing the risk 
of Salmonella infection to the whole community (Obi et al., 2007).  
 
1.12 Nosocomial Salmonellosis 
One of the contributing factors to human-to-human transmission is nosocomial 
infections. This is a secondary infection that a patient acquires after being admitted to 
a long-term medical care facility such as a hospital or a nursing home etc. (Olsen et 
al., 2001; Edelstein et al., 2004). Nosocomial outbreaks caused by salmonellae were 
common worldwide during the 1970’s, however after the implementation of control 
measures, nosocomial outbreaks have been less common in developed countries. In 
the last ten years however, there has been an alarming increase of nosocomial 
outbreaks (Edelstein et al., 2004) reported in Russia and Belarus in the 1990’s and 
1994 through to 2003 (Edelstein et al., 2004), the USA in 1996 to 1998 (Caratolli et 
al., 2002), Italy in 1998 to 2000 (Mammina et al., 2002), Spain in 1999 to 2000 
(Navarro et al., 2001) and Romania in 2002 (Miriagou et al., 2002). Reports showed 
that nosocomial infections accounted for 10% to 30% of all Salmonella cases in the 
USA (Black et al., 2004). According to the National Nosocomial Infections 
Surveillance (NNIS) System Report for January 1992 through to June 2004, most of 
the nosocomial infections reported in the USA occurred in major teaching hospitals 
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particularly in surgical, medical and paediatric intensive care units (NNIS, 2004). 
Nosocomial outbreaks due to salmonellae are common in developing countries such 
as Brazil (Olsen et al., 2001), India (Olsen et al., 2001), Tanzania (Vaagland et al., 
2004) and South Africa (Kruger et al., 2004).  
 
Most common causes of nosocomial infections are due to direct or indirect contact 
with Salmonella infected patients, hospital personnel, contaminated hospital 
environments and consumption of contaminated medication or food (Black et al., 
2004). Nosocomial infections are most severe in extremely young patients, patients 
receiving multiple antibiotic treatments, immunocompromised patients and patients 
in burn units (Riggle and Kumamato, 2000; Hanes, 2003).  
 
Studies show that nosocomial outbreaks caused by salmonellae are common in 
extremely young patients receiving parenteral nutrition as well as patients with 
central intravascular catheters (Cartolano et al., 2003). Statistical analysis shows that 
approximately 50% of all nosocomial outbreaks that occur in the USA are due to 
nosocomial infections that occur at paediatric wards (Black et al., 2004). Cartolano et 
al., (2003) described person-to-person transmission of Salmonella Brandenburg from 
an infected family member to a newborn baby in a hospital in France.  
 
In a hospital setting, antibiotic resistance is largely due to the misuse of antibiotics 
which exert selective pressure on resistance in salmonellae (Olsen et al., 2001). 
 48 
Nosocomial outbreaks caused by salmonellae in Russia and Belarus in 1994 to 2003 
were due to cefotaxime-resistant Salmonella Typhimurium isolates (Edelstein et al., 
2004). Another nosocomial outbreak in young patients was caused by CTX-M-14-
type extended-spectrum β-lactamase (ESBL) producing strains of S. enterica serotype 
London (Salmonella London) was reported by Yong et al., (2005). Olsen et al., 
(2001) described in their study the first nosocomial outbreak of fluoroquinolone 
resistant salmonellae isolated from 11 elderly patients in Oregon in the USA. In 2006, 
Wadula and colleagues (Wadula et al.,2006) described a nosocomial outbreak caused 
by S. enterica serotype Isangi (Salmonella Isangi) producing ESBL in a tertiary 
hospital in Gauteng, South Africa. A later study carried out in 2008, showed a 
nosocomial outbreak caused by ESBL producing salmonellae in Durban, South 
Africa (Govinden et al., 2008). 
 
1.13 Salmonella enterica subspecies enterica serotype Typhimurium 
Salmonella Typhimurium is a predominant serotype isolated from both humans and 
animals (Casin et al., 1999; Lim et al., 2003, Palmgren et al., 2006, Sheehan and van 
Oort, 2006). Studies show that apart from Salmonella Typhimurium causing a 
significantly high number of infections in both humans and animals worldwide, it 
raises a cause of concern because it shows the highest prevalence of antibiotic 
resistance compared to other Salmonella serotypes (Casin et al., 1999). Multidrug-
resistant Salmonella Typhimurium DT104 was first isolated in 1984 from humans 
living in the UK (Ribot et al., 2002). Studies show that Salmonella Typhimurium 
DT104 is a global concern as it is an emergent multidrug-resistant Salmonella phage 
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type in Canada, in the USA and in many European countries since the 1990’s 
(Baggesen et al, 2000; Hanes, 2003). Research shows that salmonellosis caused by 
multidrug-resistant Salmonella Typhimurium correlates with a high patient admission 
rate to medical care facilities and high patient mortality rates (Boyd et al., 2001). 
Numerous reports have been documented for Salmonella Typhimurium isolates 
recovered from humans living in North America, Central America and European 
countries, however very little data exists for human Salmonella Typhimurium isolates 
recovered from developing countries such as South Africa.  
 
1.14 
1.14.1 Global Scale 
Europe 
Belgium 
Studies show that Salmonella Typhimurium DT104 caused a major outbreak of 
Salmonella infection in Belgian livestock in 1998 (Baggesen et al., 2000).  
Denmark 
Salmonella Typhimurium together with Salmonella Enteritidis represents more than 
50% of most commonly isolated serotypes in Denmark (Torpdahl et al., 2005). A 
study performed in Denmark in 1998 showed that multidrug-resistant Salmonella 
Typhimurium DT104 caused Salmonella infection in pig herds (Baggessen et al., 
2000). 
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France 
In 1993 to 1994 and in 1998 to 2003, Salmonella Typhimurium accounted for the 
second most frequently isolated Salmonella serotype, however during the time period 
of 1995 to 1997 Salmonella Typhimurium was the first most commonly isolated 
serotype in France (Weill et al., 2006).  
Germany 
Salmonella Typhimurium DT104 was isolated from humans in Germany in 1997 
(Baggesen et al., 2000). 
Greece 
A study performed by Markogiannakis et al., (2000) showed that since 1991 through 
to 1996, Salmonella Typhimurium DT104 was commonly isolated from chicken, 
humans, pigs and pigeons.  
Italy 
Multidrug-resistant Salmonella Typhimurium DT104 was a major cause for human 
salmonellosis in 1998 in Sardinia, Italy (Baggesen et al., 2000; Weill et al., 2006). 
Ireland 
An annual report of the National Salmonella Reference Laboratory of Ireland for 
2006 (NSRL Report 2006) showed that Salmonella Typhimurium represented 23% of 
all the NTS cases. 
Netherlands 
Hendriksen et al., (2004) described in their study nonfoodborne animal-to-human 
transmission of salmonellae. Salmonella Typhimurium DT104A variant was 
transmitted to a pig, a calf and a child living on a farm.  
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United Kingdom (UK) 
Salmonella Typhimurium DT104 was first isolated from humans living in the UK in 
1984 (Ribot et al., 2002).  
Sweden 
Palmgren et al., (2006) compared the genetic relatedness between Salmonella 
Typhimurium isolates recovered from gulls with those Salmonella Typhimurium 
isolates recovered from humans and domestic animals. The results from their study 
suggested that gull Salmonella Typhimurium isolates were genetically similar to 
human and domestic animal Salmonella Typhimurium isolates and further theorized 
that gulls may play a role in spreading Salmonella Typhimurium to humans and 
domestic animals in Sweden.  
 
North America and Central America 
Canada 
Multidrug-resistant Salmonella Typhimurium DT104 was isolated from poultry in 
Canada in 1996 (Baggesen et al., 2000). 
United States of America (USA) 
Multidrug-resistant Salmonella Typhimurium DT104 was first isolated in 1985 from 
humans living in the USA, a year after it was first recovered from humans living in 
the UK (Ribot et al., 2002). It is hypothesized that Salmonella Typhimurium DT104 
was first introduced into the human population through an animal source (Ribot et al., 
2002). During 1985 to 1998 Salmonella Typhimurium ranked the most frequently 
isolated serotype in the USA (Rabatsky-Ehr et al., 2004). Multidrug-resistant 
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Salmonella Typhimurium represented less than 1% of human salmonellosis in 1980 
and represented greater than 35% in 1996 (Rabatsky-Ehr et al., 2004). In 2003 
through to 2005, Salmonella Typhimurium showed an incidence of 51% in the USA 
(Bopp et al., 1999).  
 
Asia 
India 
Saha et al., (2001) studied nosocomial isolates recovered from children who suffered 
from diarrhoeal diseases in Culcatta, India, during the time period of August 1993 to 
September 1996. Results showed that out of approximately 1000 children who 
suffered from diarrhoea, 16% (157/1000) of the cases were caused by four different S. 
enterica serotypes. Of these Salmonella Typhimurium accounted for the majority 
(70%; 110/157) of all the Salmonella serotypes. 
Israel 
Studies show that multidrug-resistant Salmonella Typhimurium DT104 was a cause 
of human salmonellosis in Israel (Baggesen et al., 2000). 
 
Africa 
Kenya 
Invasive multidrug-resistant Salmonella Typhimurium was isolated from blood 
specimens taken from children aged less than seven years in Nairobi, Kenya during a 
time period of 2002 through to 2004 (Kariuki et al., 2006). Salmonella Typhimurium 
represented the majority (55%; 106/193) of all the NTS isolates isolated from these 
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children. In addition, studies showed that Salmonella Typhimurium is a common 
cause of bacteraemia in children living in Kenya (Kariuki et al., 2006). 
Rwanda 
In 1990, multidrug-resistant Salmonella Typhimurium was responsible for a severe 
outbreak which occurred among 246 young patients living in Rwanda. Eleven percent 
(26/246) of these patients had metastatic focal infections, of which 46% (12/26) had 
meningitis caused by Salmonella Typhimurium (Lepage et al., 1990).  
Zaire 
In 1997 in Zaire, Cheesbrough et al., (1997) reported that invasive Salmonella 
Typhimurium was responsible for an outbreak in five of the 120 children. 
 
1.14.2 South Africa 
In South Africa in 1998 to 1999, multidrug-resistant Salmonella Typhimurium 
DT104 isolated from HIV-positive patients from the Chris Hani Baragwanath 
Hospital in the Gauteng Province were investigated and reported in 2000 by Crewe-
Brown and colleagues (Crewe-Brown et al., 2000). Swe Swe et al., (2006) reported a 
case of meningitis caused by Salmonella Typhimurium in an adult patient living with 
AIDS. Govinden et al., (2008) reported a nosocomial outbreak among paediatric 
patients caused by Salmonella species at a tertiary hospital in Durban, South Africa. 
Seventeen of the 41 Salmonella serotypes isolated from these patients were 
Salmonella Typhimurium. Data recorded in the Group for Enteric, Respiratory and 
Meningeal Surveillance in South Africa (GERMS-SA) surveillance database ‘Epi 
Info software’ (version 6.04d, CDC, Atlanta, USA) for the years 2003 to 2005 
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showed that a total of 7974 Salmonella isolates were received at the Enteric Diseases 
Reference Unit (EDRU), of which 28% (2270/7974) were serotyped Salmonella 
Typhimurium (Keddy, unpublished work). 
 
 
 
 
 55 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Salmonella nomenclature  
(Brenner et al., 2000) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Family: Enterobacteriaceae 
Genus: Salmonella 
Salmonella enterica Salmonella bongori (V) 
Salmonella enterica subspecies enterica (I) 
Salmonella enterica subspecies salamae (II) 
Salmonella enterica subspecies arizonae (IIIa) 
Salmonella enterica subspecies diarizonae (IIIb) 
Salmonella enterica subspecies houtenae (IV) 
Salmonella enterica subspecies indica (VI) 
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Table 1.1 Biochemical reactivity of Salmonella  
Biochemical tests for Salmonella species 
Test or substrate Reactivity 
Glucose +ve a 
ODC +ve c 
LDC +ve b 
Dulcite +ve d 
H2S +vee 
Motility test +ve e 
Indole test -ve 
Sucrose -ve 
Mannitol +ve a 
 
a
 +ve, 100% positive 
b +ve , 98% or more positive 
c +ve , 97% or more positive 
d +ve , 96% or more positive 
e +ve , 95% or more positive 
 
 (Murray et al., 1999) 
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1.15 Aims and objectives of the study 
The aim of the research presented in this dissertation was to describe the 
characterization of invasive human isolates of Salmonella Typhimurium in Gauteng, 
South Africa, 2006 through to 2008 and the characterization of salmonellae isolated 
from chickens in Gauteng, South Africa, 2007 through to 2008. The objectives were 
as follows: 
• To investigate strain relatedness and cluster formation of invasive human 
Salmonella Typhimurium isolates using the technique of PFGE analysis with 
restriction enzyme XbaI. 
• To employ MLVA as a second genotypic method to further analyze 
representative isolates of invasive human Salmonella Typhimurium isolates. 
• To enhance our understanding of the nosocomial nature of Salmonella 
Typhimurium in Gauteng. 
• To characterize chicken isolates isolated from chicken meat. 
• To investigate strain relatedness and cluster formation of human Salmonella 
isolates with chicken Salmonella isolates by PFGE analysis incorporating 
restriction enzymes XbaI and NotI. 
• To employ MLVA as a second technique to further analyse representative 
human and chicken Salmonella Typhimurium isolates. 
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CHAPTER 2 
 
Molecular epidemiology of invasive isolates of Salmonella enterica serotype 
Typhimurium in Gauteng, South Africa, 2006-2008 
2.1 Introduction 
Salmonellae on a global scale are responsible for foodborne enteric infections in 
humans and animals (Bopp et al., 1999). Salmonella Typhimurium is among the most 
common Salmonella serotypes causing Salmonella infections, internationally (Lim et 
al., 2003; Weill et al., 2006). Since 1984, Salmonella Typhimurium DT104 was 
frequently isolated from humans and animals and still continues to pose a global 
health concern (Kariuki et al., 2006; Lepage et al., 1990; Baggesen et al., 2000). In 
Europe in 1998 to 2003, Salmonella Typhimurium was the second most common 
serotype of all the other NTS serotypes responsible for most of the nosocomial 
outbreaks (Edelstein et al., 2004; Weill et al., 2006). Studies have also shown that 
Salmonella Typhimurium is a common NTS serotype responsible for severe 
infections in HIV/AIDS patients (Obi et al., 2007; Crewe-Brown et al., 2000). 
  
Very little epidemiological data exists for Salmonella Typhimurium isolates 
recovered from human patients who suffered from nosocomial acquired Salmonella 
infections and from Salmonella infected HIV-positive patients in South Africa 
(Crewe-Brown et al., 2000; Govinden et al., 2008; Swe Swe et al., 2006).  
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The aim of the current study was to clarify: 
• The molecular epidemiology of Salmonella Typhimurium isolates in Gauteng, 
South Africa, for the years 2006 through to May 2008, by using PFGE 
analysis and MLVA.  
• To enhance our understanding of the nosocomial nature of these organisms. 
• To better understand the presentation and outcome of HIV-positive patients 
(living in Gauteng) infected with Salmonella Typhimurium. 
• To identify epidemiological clusters that may assist in the interventions to 
stop further spread of disease.   
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2.2 Methods 
2.2.1 Case definition 
The Group for Enteric, Respiratory and Meningeal Disease Surveillance in South 
Africa (GERMS-SA) is a national laboratory-based surveillance system which 
monitors bacterial and fungal diseases. This program is coordinated by staff members 
who are based at the National Institute of Communicable Diseases (NICD), a branch 
of the National Health Laboratory Services (NHLS), Johannesburg. EDRU is a part 
of the GERMS-SA. As a part of routine surveillance, Salmonella isolates are sent 
from national participating laboratories in South Africa to the EDRU of the NICD for 
further phenotypic and genotypic characterization of Salmonella isolates. Salmonella 
Typhimurium isolates from all normally sterile body sites in human patients were 
included. 
 
Ethical clearance was obtained through the Human Research Ethics Committee 
(Medical), Wits University, Johannesburg (Protocol number M060449). 
 
2.2.2 Enhanced surveillance  
Surveillance officers are appointed to the four enhanced sites in Gauteng, South 
Africa (Govender et al., 2006). Surveillance officers complete basic patient 
information by interviewing patients or reviewing patient records. Information is 
recorded in the GERMS-SA surveillance database ‘Epi Info software’ (version 6.04d, 
CDC, Atlanta, USA) (Keddy, unpublished work). 
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2.2.3 Selection of isolates for analysis 
Analysis of isolates was restricted to the Gauteng Province in South Africa from 
January 2006 through to May 2008. A total of 3310 Salmonella isolates that were 
isolated from human patients was received at the EDRU, of which 36% (1194/3310) 
were serotyped Salmonella Typhimurium. Of the 1194 isolates, 840 (70%) were 
invasive Salmonella Typhimurium isolates, accounting for 25% (840/3310) of all 
Salmonella isolates. In the current study, all invasive isolates were analysed. The 
isolates were stored at -75°C in a tryptic soy broth with 10% (vol/vol) glycerol 
(Diagnostic Media Products (DMP), Sandringham, South Africa). 
 
2.2.4 Bacterial identification and phenotypic characterization  
Bacterial isolates were identified using standard microbiological techniques (See 
section 1.5 of chapter 1). Specific anti-sera (Statens Serum Institut, Copenhagen, 
Denmark; Remel Europe Ltd, Dartford, Kent, UK; and BioMérieux, Marcy-I’Ètoile, 
France) were used to serotype Salmonella Typhimurium isolates (Appendix A). This 
was performed according to the Kauffman-White scheme. 
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2.2.5 Antimicrobial susceptibility testing  
Antibiotic susceptibility was determined using Etests (AB Biodisk, Solna, Sweden) 
according to the breakpoint guidelines as published in the Clinical and Laboratory 
Standards Institute’s protocol (Appendix B) (Table 2.1). The following antibiotics 
were tested: chloramphenicol (C), streptomycin (S), tetracycline (T), nalidixic acid 
(Na), ciprofloxacin (CI), cotrimoxazole (TS), trimethoprim (TR), sulfamethoxazole 
(Su), kanamycin (KM), ampicillin (A), augmentin (XL), imipenem (IP), ceftriaxone 
(TX), cefepime (PM) and ceftazidime (TZ). For the present study, we particularly 
focused on the following six antibiotics: ampicillin (A), chloramphenicol (C), 
streptomycin (S), sulfamethoxazole (Su), tetracycline (T) and nalidixic acid (Na). 
 
2.2.6 Nosocomial isolates 
For the purpose of the current study, patients were identified as having acquired a 
nosocomial infection according to the following criteria: Salmonellosis was not 
detected on the patient’s admission to hospital and that the specimen (confirming 
salmonellosis) was taken from the patient after two or more days following hospital 
admission.  
 
2.2.7 Incomplete patient data 
Patient data corresponding to patients and patient isolates were received from 
microbiological laboratories in Gauteng. Patient demographic information such as 
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HIV status and age etc. may have been incomplete for some patients due to undefined 
reasons. Incomplete patient information was presented as unknown values in table 2.3 
and table 2.4. Missing information may have skewed results and for that reason may 
have been a drawback to the current study. However, patient data were complete for 
patients from enhanced sites.  
 
2.2.8 Pulsed-field gel electrophoresis (PFGE) analysis of isolates 
PFGE analysis was performed on isolates as previously described (Ribot et al., 2006). 
The specimen was inoculated on a 5% blood agar plate (DMP) and incubated at 37°C 
overnight. Bacterial cells were collected from the blood agar plate and were 
resuspended into 800 µl of cell suspension buffer (Appendix C). The cell 
concentration of the bacterial suspension was measured using a turbidity meter (Dade 
Behring, Randjesfontein) and turbidity readings were adjusted to approximately 0.70. 
Two hundred microlitres of the bacterial suspension was then transferred to another 
tube to which 20  µl of proteinase-K (Roche Diagnostics GmbH, Mannheim, 
Germany) (Appendix C), 28 µl of 10% SDS (Appendix C) and 275 µl of 1% agarose 
(SeaKem® Gold Agarose, Rockland, USA) (Appendix C) were added. The mixture 
(300 µl) was pipetted into moulds (Bio-Rad Laboratories, California, USA) and 
allowed to solidify for ten minutes. To lyse bacterial cells, agarose plugs containing 
genomic DNA were incubated in a shaking water bath held at 55°C, in 50 ml tubes 
containing cell lysis buffer (Appendix C). This step was performed to release 
genomic DNA. Following the lysis step, the plugs were washed once with 15 ml of 
deionized water for 15 minutes and then washed for four times with 15 ml of Tris- 
 64 
EDTA (TE) buffer for 15 minutes each (Appendix C). Bacterial DNA was digested 
by placing a slice of the agarose plug into a 150 µl solution containing 30 units of 
restriction enzyme, XbaI (Roche Diagnostics GmbH). Thereafter the slices were put 
on a comb and set in a 1% agarose gel (SeaKem® Gold Agarose) (Appendix C). 
Electrophoresis was performed using the CHEF-DR electrophoresis systems (Bio-
Rad Laboratories Inc.) in 0.5x Tris-borate EDTA (TBE) buffer (Appendix C). The 
following run parameters were used: A voltage of 6 volts, at a run temperature of 
14°C, a run time of 21 hours, an initial switch time of 2.2 seconds and a final switch 
time of 63.8 seconds. These patterns were then visualized by the UV illumination 
after staining the agarose gels with ethidium bromide (Appendix C). Fingerprint 
patterns were analysed using the BioNumerics® (version 5.1) software (Applied 
Maths, Sint-Martens-Latem, Belgium). Patterns were normalized against the 
reference pattern S. enterica serotype Braenderup (strain H9812). Dendrograms were 
produced by using the unweighted pair group method with arithmetic means. 
Analysis of the band patterns was performed with dice-coefficient at an optimization 
setting and position tolerance setting of 0.5% and 1.5%, respectively. For the purpose 
of the current study three or more isolates with a similarity value of ≥90% was 
defined as a PFGE cluster. The clusters were numbered 1, 2, 3, etc. for referral 
purposes (Please see figure 2.1 which shows an example of a typical dendrogram of 
PFGE patterns). Figure 2.1 shows isolates representing three clusters (1, 2 and 3) 
however the remaining isolates did not belong to any clusters due to the criteria 
described above.  
  
 65 
2.2.9 Preparation of crude bacteria DNA 
Bacterial cells were suspended in 400 µl of TE buffer (Appendix C) and boiled at 
95°C for 25 minutes. Thereafter the bacterial suspension was centrifuged at 3500 rpm 
for three minutes. The supernatant was used directly in the PCR reactions.  
   
2.2.10 Multiple-locus variable-number tandem-repeats analysis (MLVA) 
MLVA was based on five VNTR gene loci (STTR3, STTR5, STTR6, STTR9 and 
STTR10pl) as previously described by Lindstedt et al., (2004). The PCR primers 
used to amplify VNTR loci are seen in table 2.2. The forward primer for each locus 
was labelled with a distinctive fluorescent dye (Qiagen, Venlo, Netherlands). The 
Qiagen PCR multiplex kit (Qiagen) was used to multiplex these five primer pairs into 
two solutions. Solution one was made up as follows: 12.5 µl of PCR master mix, 9.5 
µl of RNAnase free water, 2.5 µl of primer mix which comprised of 10 pmol each of 
the STTR3 and STTR6 primer pairs and 0.5 µl of crude bacterial DNA, all of which 
made up a total volume of 25 µl. For solution two, the same volume of PCR master 
mix, RNAnase free water, crude bacterial DNA and primer mix were added, except 
the primer mix comprised of 10 pmol each of the STTR5, STTR9 and STTR10pl 
primer pairs. PCR was performed using the Bio-Rad Thermal i-Cyler (Bio-Rad 
Laboratories Inc.). The PCR run conditions were as follows: 95°C for 15 minutes; 25 
cycles of 94°C for 30 seconds, 63°C for 90 seconds and 72°C for 90 seconds; and a 
hold at 72°C for ten minutes. The two resultant PCR solutions were pooled as 
follows: 10 µl of solution one + 2.5 µl of solution two. This pooled mixture was then 
diluted 1:7 in deionised water. One microlitre of this diluted mixture was then mixed 
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with 1 µl of GeneScan™ 600 LIZ® size standard (Applied Biosystems, Foster city, 
USA) and 12 µl of Hi-Di™ formamide (Applied Biosystems). This 14 µl mixture was 
then incubated at 95°C for three minutes and cooled to room temperature before 
being subjected to capillary electrophoresis using an Applied Biosystems 3130 
Genetic Analyzer. Electrophoresis was performed through POP-7 polymer (Applied 
Biosystems) with an injection voltage of 15 kV for five seconds at a temperature of 
60°C. Raw data were captured and analyzed using GeneMapper® (version 4.0) 
software (Applied Biosystems). VNTR locus was identified by its distinctive colour 
(fluorescence) and the gene product was sized by comparison to the internal size 
standard. Data (fragment lengths) were then entered into BioNumerics® v5.1 
(Applied Maths). Dendrograms were produced by using Euclidian distance and Ward 
algorithm. Isolates were considered identical if they were identical at all loci. Isolates 
were considered closely related if they were polymorphic at only one locus. Isolates 
were considered unrelated if they were polymorphic at two or more loci. 
 
2.2.11 Statistical analysis  
In addition to descriptive analysis, univariate logistic regression was performed to 
determine which individual explanatory variables were significantly associated with 
the outcome variables – HIV status and nosocomial infections – by calculation of 
unadjusted odds ratios and 95% confidence intervals. 
 
 67 
2.3 Results and Discussion 
2.3.1 PFGE analysis and clusters of isolates  
PFGE analysis was performed on 840 invasive human Salmonella Typhimurium 
isolates collected from different referral hospitals in the Gauteng Province in South 
Africa from January 2006 through to May 2008. Of the 840 invasive human isolates, 
80% (671/840) of the isolates could be grouped into distinctive clusters. For the 
remainder of this chapter, presentation and discussion of data was focused on these 
671 isolates. These data are summarized in table 2.3. For January 2006 through to 
May 2008, a total of 38 clusters (1 to 38) were identified amongst these 671 isolates. 
The smallest cluster was represented by three isolates and the largest cluster was 
represented by 160 isolates. Of the 38 clusters identified, three clusters (3, 5 and 11) 
were primary clusters represented by 116 (17%), 160 (24%) and 116 (17%) isolates, 
respectively. Three secondary clusters (7, 10 and 20) were categorized into the isolate 
number range of 29 (4%) to 43 (6%) of 671. Small numbers of isolates (n≤12 
isolates) made up the remaining 32 clusters.  
 
2.3.2 Hospital of origin 
Human isolates were sourced from 21 hospitals in the Gauteng Province. Seven 
hospitals accounted for 92% (616/671) of all isolates (Table 2.3). Most isolates (48%; 
324/671) originated from Hospital 2, a major public and teaching hospital located in 
Gauteng (van de Heever, 2008). For three hospitals (H1, H2 and H49) (14%; 3/21), 
some evidence was found for nosocomial acquisition of isolates, of which Hospital 2 
accounted for most nosocomial isolates. Research has shown that Salmonella 
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infections are more common in a hospital environment due to overcrowding of 
patients and insufficient medical staff (Bouallègue-Godet et al., 2003). In addition, 
Salmonella infections in hospitals are usually associated with the use of contaminated 
medical equipment and the consumption of contaminated meals served at hospitals. 
Food may be contaminated as a result of poor hand hygiene and inadequate cooking 
of meals by kitchen staff (Bouallègue-Godet et al., 2003). The above mentioned 
examples may account for possible routes by which the majority of the clusters could 
have circulated in Hospital 2. Cluster 5 was a predominant cluster (24%; 160/671) in 
all 21 hospitals in Gauteng from January 2006 to May 2008 and was thus responsible 
for most of the infections caused by Salmonella Typhimurium during these years. 
 
2.3.3 Age-range of patients 
Most of the isolates (56%; 376/671) came from patients between 15 and 64 years of 
age (Table 2.3). Surveillance studies performed in South Africa for the years 2006 
and 2007 have also shown that salmonellae are more frequently isolated from patients 
in this age-range (Govender et al., 2006; Govender et al., 2007). Furthermore, the 
majority (61%; 229/376) of the isolates from patients in this age-range were 
represented in clusters 3 (20%), 5 (24%) and 11 (17%). Twenty-nine percent 
(195/671) of the isolates came from patients aged four years and younger (Table 2.3). 
Young patients have an immature immune system and are more prone to Salmonella 
infections and hence this finding is not unexpected (Olesen et al., 2005; Ikumapayi et 
al., 2007). The majority (58%; 113/195) of the isolates from this young age-range 
were represented in clusters 3 (10%), 5 (24%) and 11 (24%). Of the 671 isolates, only 
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three isolates were recovered from patients aged 65 years and older (Table 2.3). Older 
patients are usually more predisposed to acquiring salmonellosis as a secondary 
infection as a result of their weakened immunity (Hanes, 2003). Conversely, the 
results in the current study suggest that salmonellosis in elderly patients in Gauteng 
for 2006 to 2008 occurred relatively less frequently. These results could possibly be 
accounted for by the underreporting of Salmonella cases in older patients due to 
numerous undefined reasons (Hanes, 2003) or overwhelming salmonellosis identified 
in patients of other age-ranges (less than 65 years) due to the high burden of HIV 
infection in these age-ranges (Cheesbrough et al., 1997; Kuppermann, 1999; 
Kankwatira et al., 2004; Ikumapayi et al., 2007).  
 
2.3.4 HIV disease 
In the current study, the HIV status of patients was only known for 41% (277/671) of 
the patients, of which 92% (256/277) were HIV-positive (Table 2.3). Patients in the 
15-64 year age-range were 12.3 times more likely to be HIV-positive than patients in 
the 0-4 age-range (P<0.001; 95% CI [3.4-43.8]). The majority (61%; 156/256) of the 
isolates from HIV-positive patients fell in the clusters 3 (21%), 5 (27%) and 11 
(14%). HIV is a life-threatening epidemic in South Africa and accounts for up to 
1000 deaths of AIDS patients, daily (Pembrey, 2008). Statistical reports have shown 
that in South Africa at the end of 2007, approximately 5.7 million people were living 
with HIV (Pembrey, 2008). HIV destroys the immune cells in the gut and predisposes 
HIV-positive patients to NTS: infection is 20 times more likely compared to 
immunocompetent patients (Hanes, 2003; Fernandez Guerrero et al., 1997). Despite 
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the unknown HIV status for 59% (394/671) of the patients in the current study, the 
results still suggests that Salmonella Typhimurium may be responsible for extensive 
co-morbidity suffered by HIV-positive patients living in the Gauteng Province of 
South Africa.  
 
2.3.5 Antibiotic resistance profiles 
Antibiotic resistance profiles of Salmonella isolates are shown in Table 2.3. The most 
commonly expressed antibiotic resistance profiles of isolates from all the PFGE 
clusters were: ACSSuTNa (12%; 82/671) and ACSSuNa (13%; 90/671). Previous 
studies have shown that the penta-resistant ACSSuT pattern is frequently reported in 
Salmonella Typhimurium strains isolated in the UK, France and North America 
(Casin et al., 1999; Helms et al., 2005). An increase in resistance to the quinolone 
class of antimicrobials (nalidixic acid) in addition to the penta-resistant pattern has 
also been documented in an international survey performed on representative isolates 
of Salmonella Typhimurium for the years 1992 to 2001 (Helms et al., 2005). For the 
current study, antibiotic resistance in the primary clusters (3, 5 and 11) are as follows: 
For cluster 3, 91% (105/116) of the isolates were resistant to three or more 
antibiotics. The most distinguishing features for the majority of the isolates in cluster 
3 were that they expressed the following multidrug-resistant patterns: ACSSuTNa 
(18%), ACSuTNa (10%), ASSuTNa (9%), ASSuT (15%), ASuNa (9%) and ASu 
(9%). For cluster 5, 91% (145/160) of the isolates were resistant to three or more 
antibiotics. The most common antibiotic resistance profiles were ACSSuTNa (21%), 
ACSSuNa (39%) and ACSSu (14%). In cluster 3 and 5, the majority of the isolates 
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were multidrug-resistant isolates and this suggests that treatment given to patients 
with Salmonella Typhimurium may be compromised resulting in longer morbidity 
periods and possibly a higher death rate amongst patients. Cluster 11 (n=116) 
included our largest group of antibiotic susceptible isolates. Cluster 11 included 45 
isolates showing susceptibility to all six antibiotics and 26 isolates showing resistance 
to sulfamethoxazole only. In addition, 21 isolates represented in cluster 11 expressed 
the resistance profile, SuT. For this cluster of isolates, the treatment given to patients 
may be uncomplicated and morbidity may possibly be less severe. 
 
2.3.6 Nosocomial isolates  
Of the 671 isolates, only 383 had data which allowed us to draw conclusions as to 
possible nosocomial acquisition of the isolate. Of these 383 isolates, 35 (9%) were 
identified as nosocomial isolates: these isolates fell into 12 clusters (Table 2.4). 
Ninety-four percent (33/35) of the nosocomial isolates were recovered from patients 
with a known HIV status, of which the most distinctive feature was that the majority 
of the isolates came from HIV-positive patients (97%; 32/33) and from patients in the 
age-range of 15 to 64 years (66%; 23/35). All the nosocomial isolates were sourced 
from only three hospitals (H1, H2 and H49), with patients from Hospital 49 being 
18.8 times more likely than patients in Hospital 1 to have nosocomial infections 
(P<0.004; 95% CI [2.7-129.7]) and 4.8 times more likely than patients in Hospital 2 
to have nosocomial infections (P<0.02; 95% CI [1.2-19.0]). In addition, patients from 
Hospital 2 were 3.9 times more likely than patients from Hospital 1 to have 
nosocomial infections (P<0.1; 95% CI [0.9-17.0]). Hospital 2 accounted for the 
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majority (83%; 29/35) of the nosocomial isolates: these isolates belonged to multiple 
clusters. Isolates in cluster 3 were 6.2 times more likely than those in cluster 5 to be 
nosocomial. P<0.001; 95% CI [2.3-16.8] and 8.1 times more likely than those in 
cluster 11 to be nosocomial. P<0.003; 95% CI [2.1-31.2]). Most of our 35 nosocomial 
isolates were encompassed in clusters 3 (31%; 11/35) and 5 (23%; 8/35). Further 
discussion will be focussed only on these two clusters. 
 
Cluster 3 
A total of 11 nosocomial isolates fell in cluster 3, all of which were isolated from 
patients hospitalized at Hospital 2 (Table 2.4). Hospital 2 is a large academic hospital 
which accommodates not only patients living in the surrounding areas in the Gauteng 
Province, but also serves as a referral hospital for a large part of South Africa and 
neighbouring African countries (van de Heever, 2008). Past studies have shown that 
nosocomial infections occurred most commonly when there was an over population 
of patients and relatively fewer health care workers. There tends to be a reduction in 
infection control practiced by health care professionals to comply with the demand of 
seeing and treating an increased number of patients (Bouallègue-Godet et al., 2003) 
which could possibly account for the high number of nosocomial isolates in Hospital 
2. Infection in Hospital 2 could also have been acquired through direct contact 
(person-to-person) or through contact with common contaminated surfaces in the 
hospital environment (Hanes, 2003). Eight of the 11 (73%) nosocomial isolates were 
from patients aged 15 to 64 years (Table 2.4). These results were similar to the 
findings reported by Govender et al., (2006; 2007). Nine of the ten (90%) nosocomial 
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isolates which came from patients with a known HIV status were HIV-positive. 
These results support the observation of previous studies, that immunocompromised 
patients such as HIV-positive patients are more susceptible to nosocomial infections 
(Hanes, 2003). Ten of the 11 (91%) nosocomial isolates were resistant to three or 
more antibiotics. The earliest isolate was sourced in February 2006 and the most 
recent isolate was sourced in August 2007, suggesting that this nosocomial cluster 
has been circulating in Hospital 2 for at least 19 months. 
 
Cluster 5 
Eight nosocomial isolates fell within cluster 5 (Table 2.4). Seven (88%) isolates were 
from Hospital 2 and one (13%) isolate was received from Hospital 49. All the isolates 
were from patients who were HIV-positive as found in other studies (Hanes, 2003). 
Five (63%) of the isolates were from patients aged 15 to 64 years, while three (38%) 
of the isolates were from patients aged four years and younger. All seven nosocomial 
isolates from Hospital 2 were resistant to four or more antibiotics. Nosocomial 
outbreaks caused by multidrug-resistant Salmonella Typhimurium are commonly 
reported (Olsen et al., 2001; Govinden et al., 2008). The earliest isolate was sourced 
in January 2006 and the most recent isolate was sourced in July 2007, suggesting that 
this nosocomial cluster has been circulating in Hospital 2 for at least 19 months. 
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2.3.7 Evaluation of multiple-locus variable-number tandem-repeats analysis 
(MLVA) for genotyping South African isolates of Salmonella Typhimurium  
MLVA was performed as per the method described by Lindstedt et al., (2004). The 
MLVA profile of an isolate constitutes a report of the size of five gene loci and is 
reported in the following genetic order: STTR9-STTR5-STTR6-STTR10pl-STTR3. 
MLVA was performed on 21 isolates which all were found to have a 100% identical 
PFGE profile. MLVA separated these 21 isolates into 11 distinct MLVA types (3, 15, 
28, 29, 30, 31, 32, 33, 34, 35 and 36) (Figure 2.2). Most isolates (n=10) showed 
MLVA type 3 (160-216-342-370-450). MLVA type 3 differed to MLVA type 30 
(160-216-356-370-450) at only one locus, so these MLVA types were very similar. 
Isolates (n=2) showing MLVA type 30 were considered to be closely related to the 
ten isolates showing MLVA type 3. A second example of very similar MLVA types 
were MLVA type 29 (160-216-328-325-450) and MLVA type 35 (160-216-314-325-
450), of which isolates showing these MLVA types were considered to be closely 
related. Furthermore, this MLVA investigation has shown that the STTR5, STTR6 
and STTR 10pl loci, displayed high degrees of polymorphisms for most isolates and 
thus suggesting that these loci are the best loci for high discriminative subtyping of 
South African isolates of Salmonella Typhimurium. Similar findings were reported 
by Lindstedt et al., (2004) who showed that the same three loci (STTR5, STTR6 and 
STTR10pl) were polymorphic in allele distribution for most Salmonella 
Typhimurium isolates included in their study. In this current study, MLVA was able 
to discriminate Salmonella Typhimurium isolates that have the same PFGE profiles. 
Similar findings were shown in a study carried out by Witonski and colleagues 
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(Witonski et al., 2006). Salmonella Typhimurium isolates recovered from human 
patients showed identical PFGE patterns. When MLVA was performed on these 
isolates, results showed that some of the isolates were distinguishable from one 
another whereas other isolates had identical MLVA profiles to each other (Witonski 
et al., 2006). 
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Table 2.1 Antibiotics tested and breakpoints of antibiotics.  
 
CLSIa breakpoints  Antibiotic  
S R 
Ampicillin < 8    >32 
Chloramphenicol ≤ 8 ≥ 16 
Streptomycin 0 ≥ 64 
Sulfamethoxazole ≤ 256 ≥ 512 
Tetracycline ≤ 4 ≥ 8 
Nalidixic acid  ≤ 16 ≥ 32 
 
a(CLSI, 2005) 
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Table 2.2 Primers selected for PCR 
 
MLVA primer name  Dye sequences (5’-3’) 
STTR3-F 6FAM-CCCCCTAAGCCCGATAATGG 
STTR3-R TGACGCCGTTGCTGAAGGTAATAA 
STTR5-F VIC-ATGGCGAGGCGAGCAGCAGT 
STTR5-R GGTCAGGCCGAATAGCAGGAT 
STTR6-F NED-TCGGGCATGCGTTGAAA 
STTR6-R CTGGTGGGGAGAATGACTGG 
STTR9-F 6FAM-AGAGGCGCTGCGATTGACGATA 
STTR9-R CATTTTCCACAGCGGCAGTTTTTC 
STTR10pl-F PET-CGGGCGCGGCTGGAGTATTTG 
STTR10pl-R GAAGGGGCCGGGCAGAGACAGC 
 
(Lindstedt et al., 2004) 
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Table 2.3 Division of Salmonella Typhimurium isolates into PFGE clusters followed by further subdivision by: hospital of 
origin, age- range of patients, HIV status of patients and antibiotic resistance profile (actual numbers of isolates are shown)    
 
   PFGE cluster 
 
 
 3 
(n=116)  
5  
(n=160) 
7 
 (n=43)  
10  
(n=34)  
11  
(n=116)  
20 
 (n=29)  
Othera  
(n=173) 
Total 
(n=671) 
H1 13 24 2 2 17 4 20 82 
H2 70 77 14 12 48 19 84 324 
H17 8 23 11 7 17 3 30 99 
H18 7 3 5 2 7 1 9 34 
H30 2 5 0 6 8 0 8 29 
H46 6 15 0 1 5 0 5 32 
H49 1 2 7 2 3 0 1 16 
Hospital of 
originb 
Otherc 9 11 4 2 11 2 16 55 
≤4 years 20 47 12 8 46 13 49 195 
5-14 years 4 4 2 2 1 0 9 22 
15-64 years 75 91 25 22 63 11 89 376 
≥65 years 0 1 1 0 1 0 0 3 
Age-range of 
patients 
unknown 17 17 3 2 5 5 26 75 
+ve  53 68 14 9 35 10 67 256 
-ve 4 1 2 0 5 1 8 21 
HIV status of 
patients 
unknown 59 91 27 25 76 18 98 394 
ACSSuTNa 21 34 1 1 2 3 20 82 
ACSSuT 2 5 3 0 2 4 10 26 
ACSSuNa 7 63 8 0 2 0 10 90 
ACSuTNa 12 2 2 0 1 1 7 25 
ACSSu  0 23 4 0 3 0 8 38 
ACSNa 0 0 1 0 0 0 0 1 
ACSuT  2 0 0 0 0 8 2 12 
ACSuNa  2 3 0 0 0 0 0 5 
ASSuTNa 11 0 2 0 0 1 2 16 
ASSuT  17 3 2 2 0 2 5 31 
ASSuNa 8 5 5 0 0 0 2 20 
ASTNa 1 0 0 0 0 0 0 1 
ACT 0 0 0 1 0 0 1 2 
ASSu 2 2 2 1 0 1 6 14 
ASuT 5 0 0 0 1 0 3 9 
ASuTNa   4 0 1 0 0 0 3 8 
ASuNa 11 5 1 1 0 0 9 27 
SSuT 0 0 0 0 2 0 6 8 
CSuT 0 0 0 0 0 0 1 1 
Antibiotic 
resistance 
profiled 
ASu 11 3 4 1 0 2 12 33 
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AT                         0 1 0 0 0 0 0 1 
CSu 0 0 0 0 0 0 1 1 
SSu    0 0 0 0 0 0 1 1 
SuT     0 1 1 5 21 0 10 38 
SuNa     0 0 1 0 0 0 2 3 
Su   0 3 2 10 26 3 21 65 
TNa   0 1 0 0 0 0 0 1 
A 0 1 0 0 0 0 1 2 
C 0 0 0 1 0 0 0 1 
T   0 1 0 1 8 1 4 15 
Na    0 0 0 0 2 0 3 5 
susceptible 0 3 3 10 45 4 24 89 
 
a These represent the remaining  32 clusters 
b H1, Hospital 1; H2, Hospital 2; H17, Hospital 17; H18, Hospital 18; H30, Hospital 30; H46, Hospital 46; H49, 
Hospital 49 
c These represent the remaining 14 hospitals 
d A, Ampicillin; C, Chloramphenicol; S, Streptomycin; Su, Sulfamethoxazole, T, Tetracycline; Na, Nalidixic acid; 
susceptible, susceptible to all 6 of the former mentioned antibiotics 
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Table 2.4 Attributes of nosocomial isolates of Salmonella Typhimurium 
 
 
Isolate 
number 
PFGE cluster Hospital of 
origina     
Month/year of isolation Antibiotic resistance profileb
  
Age-range of 
patients  
(years) 
 
HIV Status of 
patients 
N600 3 H2 February 2006 ASSuTNa 5-14 -ve 
N637 3 H2 February 2006 ASSuT ≤4 +ve 
N503 3 H2 April 2006 ACSuTNa 15-64 +ve 
N282 3 H2 May 2006 ACSSuTNa 15-64 +ve 
N283 3 H2 May 2006 ACSSuTNa 15-64 +ve 
N312 3 H2 May 2006 ASSuT 15-64 +ve 
N093 3 H2 June 2006  ACSSuTNa 15-64 unknown 
N196 3 H2 June 2006 ACSSuTNa 15-64 +ve 
N591 3 H2 August 2006 ASuNa 15-64 +ve 
N039 3 H2 January 2007 ASu ≤4 +ve 
N636 3 H2 August 2007 ACSuTNa 15-64 +ve 
N367 5 H2 January 2006 ACSuTNa 15-64 +ve 
N200 5 H2 March 2006 ACSSuNa 15-64 +ve 
N038 5 H2 February 2007 ACSSuNa 15-64 +ve 
N859 5 H2 February 2007 ACSSuTNa ≤4 +ve 
N810 5 H49 February 2007 ASu ≤4 +ve 
N767 5 H2 May 2007  ACSSuTNa ≤4 +ve 
N520 5 H2 July 2007  ASSuT 15-64 +ve 
N537 5 H2 July 2007  ASSuT 15-64 +ve 
N801 7 H49 June 2006  Su ≤4 +ve 
N487 7 H2 January 2008  SuT 15-64 +ve 
N956 10 H49 March 2008 susceptible 15-64 +ve 
N402 10 H1 November 2007 Su 15-64 unknown 
N599 11 H2 May 2006  susceptible 15-64 +ve 
N511 11 H2 July 2007 Su ≤4 +ve 
N213 11 H49 October 2007 Su 15-64 +ve 
N012 18 H1 August 2006 ACSuTNa 15-64 +ve 
N787 21 H2 June 2006 susceptible  ≤4 +ve 
N197 22 H2 June 2006 SSu ≤4 +ve 
N771 22 H2 June 2006 ASSu ≤4 +ve 
N520 25 H2 July 2007 ASSuT 15-64 +ve 
N511 25 H2 July 2007 Su ≤4 +ve 
N196 29 H2 June 2006 ACSSuTNa 15-64 +ve 
N624 31 H2 April 2008 SuT 15-64 +ve 
N708 36 H2 September 2006 ASuNa 15-64 +ve 
 
a H1, Hospital 1; H2, Hospital 2; H49, Hospital 49 
b A, Ampicillin; C, Chloramphenicol; S, Streptomycin; Su, Sulfamethoxazole, T, Tetracycline; Na, Nalidixic acid; 
susceptible, susceptible to all 6 of the former mentioned antibiotics 
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Figure 2.1 Dendrogram analysis of XbaI-digested DNA of Salmonella Typhimurium isolates.  A percentage scale 
of similarity is shown above the dendrogram. The purple dotted line indicates the 90% similarity value. 
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Figure 2.2 Dendrogram of representative MLVA-typed Salmonella Typhimurium isolates in the current study. Lanes 1-5: MLVA 
profile in the order: STTR9-STTR5-STTR6-STTR10pl-STTR3. Lanes 9-14 (Former mentioned antibiotics): Na, Nalidixic acid; 
A, Ampicillin; Su, Sulfamethoxazole, C, Chloramphenicol; T, Tetracycline; S, Streptomycin; -, susceptible. 
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CHAPTER 3 
 
Characterization of Salmonella isolated from chickens in Gauteng, South Africa, 
2007-2008; and comparison to invasive human isolates  
 
3.1 Introduction 
 
Salmonellae are a frequently isolated foodborne zoonotic pathogen in humans and 
animals. Salmonellosis is mostly caused by the consumption of food and water that 
are contaminated with salmonellae (Bopp et al., 1999). Contamination of food with 
salmonellae can occur during and after food preparation (Mosupye and von Holy, 
1999). Studies show that about 1% to 50% of meat sold at commercial markets is 
contaminated with bacterial pathogens during slaughtering and processing of food 
animals (Hanes, 2003). Cross-contamination of cooked food is often due to poor 
hygiene practiced during food preparation (Mosupye and von Holy, 1999). 
Furthermore, the use of antimicrobials in food animals by food production industries 
has led to an increase in the development of bacterial resistance to multiple antibiotics 
and consequently further complicates treatment for humans (Velge et al., 2005). 
Previous reports showed that salmonellae is more frequently isolated from poultry 
and poultry products in comparison to any other animal species and is a major source 
of salmonellosis in humans (Carli et al., 2001; Cardinale et al., 2003; Myint, 2004; 
Giannatale et al., 2008). Salmonellae are a significant burden to the economy 
worldwide, particularly to the poultry industry due to productivity losses (Sarwari et 
al., 2001; Nógrády et al., 2007). Worldwide data for the years 1950 to 1970 showed 
that Salmonella Typhimurium was the most common Salmonella serotype isolated 
from poultry (Poppe, 2000). However, studies performed in 1984 through to 1999 
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showed that Salmonella Enteritidis replaced Salmonella Typhimurium as the most 
prevalent serotype isolated from poultry and eggs (Altekruse et al., 2006) and 
correlated with the increase in the number of Salmonella Enteritidis isolates 
recovered from humans (Lee, 1974; Rabsch et al., 2000). In the late 1990’s, this 
problem was addressed by the implementation of quality assurance programs by 
poultry and egg production industries. This led to a 50% reduction in the number of 
cases of human salmonellosis caused by Salmonella Enteritidis (Poppe, 2000; 
Altekruse et al., 2006).  
 
The current study was performed to investigate the prevalence of salmonellae in 
chickens sold at formal and informal outlets in the Gauteng Province of South Africa 
and to determine whether a genetic relationship exists between these chicken isolates 
and human isolates in Gauteng. 
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3.2 Materials and Methods 
 
3.2.1 Origin of Salmonella isolates  
Chicken isolates 
Chicken Salmonella isolates were isolated from chicken specimens which were 
purchased from retail and informal outlets such as formal and informal shops, street 
vendors and home-based abattoirs from various regions in Gauteng during the time 
period of September 2007 through to April 2008. These isolates were stored at -75°C 
in a tryptic soy broth with 10% (vol/vol) glycerol (DMP). 
 
Human isolates   
Chicken isolates were compared to human isolates. Human isolates were restricted to 
those which were isolated from patients from different referral hospitals in the 
Gauteng Province. These isolates were received at the EDRU for routine surveillance. 
Chicken isolates of various serotypes were compared to equivalent serotypes of 
representative human isolates which were received during the time period of January 
2007 through to May 2008 with the exception of human Salmonella Typhimurium 
isolates. Chicken Salmonella Typhimurium isolates were compared to invasive 
human Salmonella Typhimurium isolates that were received from different referral 
hospitals in the Gauteng Province during the time period of January 2006 to May 
2008. 
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3.2.2 Isolation and identification of Salmonella from chicken meat 
Salmonellae were isolated from chicken meat using standard microbiological 
procedures (Appendix D).  
 
3.2.3 Bacterial identification and phenotypic characterization  
Bacterial identification and phenotypic characterization was performed on human and 
chicken Salmonella isolates. This method has already been described (See section 
2.2.4 of chapter 2).  
 
3.2.4 Antimicrobial susceptibility testing  
Antibiotic susceptibility testing was determined using the Etests on all human and 
chicken Salmonella isolates in the current study. This method has already been 
described (See section 2.2.5 of chapter 2). 
 
3.2.5 Pulsed-field gel electrophoresis (PFGE) analysis of isolates 
PFGE analysis was performed on all human and chicken Salmonella isolates as 
previously described (See section 2.2.8 of chapter 2). In addition to this, secondary 
PFGE analysis was performed on human and chicken Salmonella isolates (excluding 
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Salmonella Typhimurium isolates) using restriction enzyme NotI (Inqaba 
Biotechnical Industries (Pty.) Ltd., Pretoria, South Africa). 
 
3.2.6 Multiple-locus variable-number tandem-repeats analysis (MLVA) 
MLVA was performed for secondary genotypic analysis of Salmonella Typhimurium 
isolates. This method has already been described (See section 2.2.9 and 2.2.10 of 
chapter 2).  
 
3.2.7 Interpretation of genotypic data and determining relationships between 
chicken and human isolates 
Chicken and human isolates of the same serotype were considered to be closely 
related only when two different genotyping methods both revealed significant 
similarity between the isolates.  
 
For Salmonella Typhimurium, the two genotyping methods were PFGE analysis 
(XbaI digestion) and MLVA. Two isolates of Salmonella Typhimurium were 
considered to be closely related when their PFGE patterns were at least 90% similar 
and their MLVA profiles differed at no more than one locus. 
 
For all other Salmonella serotypes, the two genotyping methods were PFGE analysis 
(XbaI digestion) and PFGE analysis (NotI digestion). Two isolates of the same 
Salmonella serotype were considered to be closely related when their XbaI PFGE 
 88 
patterns were at least 90% similar and their NotI PFGE patterns were at least 90% 
similar.    
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3.3 Results and Discussion 
3.3.1 Salmonella serotypes isolated from chicken meat 
One-hundred and fifty chickens were processed and 47 Salmonella strains were 
isolated. S. enterica serotype Heidelberg (Salmonella Heidelberg) (34%; 16/47) and 
S. enterica serotype Infantis (Salmonella Infantis) (34%; 16/47) were the most 
common Salmonella serotypes isolated from chickens; followed by S. enterica 
serotype Hadar (Salmonella Hadar) (11%; 5/47), Salmonella Enteritidis (11%; 5/47) 
and Salmonella Typhimurium (11%; 5/47). Salmonella Enteritidis (Lee, 1974; Poppe, 
2000; Rabsch et al., 2000; Altekruse et al., 2006), Salmonella Infantis (Poppe, 2000; 
Kudaka et al., 2006; Nógrády et al., 2007), Salmonella Heidelberg (Poppe, 2000; 
Nayak and Kenney, 2002; Myint, 2004), Salmonella Hadar (Poppe, 2000; Cruchaga 
et al., 2001; Sarwari et al., 2001; Giannatale et al., 2008) and Salmonella 
Typhimurium (Poppe, 2000; Heuzenroeder et al., 2004; Wedel et al., 2005; Zaidi et 
al., 2007; Harnett et al., 1998) are common serotypes recovered from poultry and 
poultry products.  
 
3.3.2 Salmonella Infantis  
Salmonella Infantis was one of the most (34%; 16/47) isolated serotypes from 
chicken meat. PFGE analysis with XbaI digestion and with NotI digestion grouped 16 
chicken isolates into four distinct clusters (Figure 3.1 and Figure 3.2). Cluster 1 was 
the largest cluster which is comprised of eight (50%; 8/16) chicken isolates which 
were isolated from chickens that were purchased from two different areas in the 
Johannesburg metropolitan (Soweto) (Figure 3.1 and Figure 3.2). All eight chicken 
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isolates from cluster 1 were susceptible to all six former mentioned (ACSSuTNa) 
antibiotics (Figure 3.1 and Figure 3.2). Cluster 2 shown in figure 3.1 and figure 3.2 
was the smallest cluster and was represented by a single chicken isolate (TCD F56) 
which was resistant to tetracycline. Cluster 3 (Figure 3.1 and Figure 3.2) was 
represented by two (13%; 2/16) chicken isolates (TCD F54 and TCD F58) which 
were isolated from chickens that were purchased from two different areas in the 
Johannesburg metropolitan (Soweto). One of the two chicken isolates (TCD F54) 
showed susceptibly to all 6 (ACSSuTNa) antibiotics, whereas the remaining isolate 
(F58) was resistant to tetracycline. Cluster 4 (Figure 3.1 and Figure 3.2) was 
represented by five chicken isolates (31%; 5/16) which were isolated from chicken 
meat purchased from the same area in the Johannesburg metropolitan (Soweto). Four 
of the five chicken isolates (80%) were resistant to chloramphenicol, streptomycin, 
sulfamethoxazole and tetracycline, while the remaining isolate was resistant to 
streptomycin and tetracycline. PFGE analysis with XbaI digestion (Figure 3.1) and 
NotI digestion (Figure 3.2) showed that the PFGE patterns of chicken isolates were 
completely different to all PFGE patterns of human isolates, implying that these 
chicken isolates were unrelated to our human isolates. A study performed by 
Pelkonen et al., (1994) in Finland showed that human Salmonella Infantis isolates for 
the years 1980 and 1989 compared to chicken Salmonella Infantis isolates collected 
from five broiler chicken companies for the years 1986 to 1991 were not related by 
molecular subtyping (Pelkonen et al., 1994). Similar results were found between 
human and chicken Salmonella Infantis isolates by PFGE analysis in the current 
study. In contrast to the current study, a study performed by Nógrády et al., (2007) in 
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Hungary, showed that broiler chicken and human Salmonella Infantis isolates were 
related by XbaI PFGE fingerprinting.  
 
3.3.3 Salmonella Enteritidis 
Salmonella Enteritidis was one of the least frequently isolated serotypes (11%; 5/47) 
from chicken meat (Figure 3.3 and Figure 3.4). Chicken isolates were recovered from 
chicken meat which were purchased from the Ekurhuleni metropolitan (Tembisa) and 
Johannesburg metropolitan (Soweto) in Gauteng. The majority of the isolates (80%; 
4/5) were susceptible to all six antibiotics. PFGE analysis with XbaI digestion (Figure 
3.3) and NotI digestion (Figure 3.4) showed that the PFGE patterns of chicken 
isolates were completely different to all PFGE patterns of human isolates, implying 
that chicken isolates were unrelated to our human isolates. Data from other countries 
showed that an increase in the number of Salmonella Enteritidis isolated from 
chicken meat and eggs, correlated with an increase in Salmonella Enteritidis isolates 
from humans (Lee, 1974; Poppe, 2000; Rabsch et al., 2000). In New York in the 
USA in 1987, the consumption of contaminated poultry and poultry products 
prepared at acute and long term care hospitals led to the largest hospital outbreak of 
human salmonellosis caused by Salmonella Enteritidis (Poppe, 2000). A case study 
carried out in the late 1980s in England and more recent studies carried out in the 
years 2004 and 2006 in the USA showed that consumption of chicken meat 
contaminated with Salmonella Enteritidis predisposed humans to sporadic cases of 
salmonellosis (Altekruse et al., 2006). However, unlike the results outlined in the 
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above mentioned studies, the results found in our study exhibited no link between 
human and chicken Salmonella Enteritidis isolates in Gauteng, South Africa.  
 
3.3.4 Salmonella Heidelberg 
Salmonella Heidelberg was one of the most frequently isolated serotypes (34%; 
16/47) from chicken meat (Figure 3.5 and Figure 3.6). These chicken isolates were 
isolated from chicken meat which were purchased from various areas in the 
Johannesburg metropolitan (Soweto), the Ekurhuleni metropolitan (Tembisa) and the 
Tshwane metropolitan (Pretoria) in Gauteng. The majority (63%; 10/16) of the 
chicken isolates were resistant to chloramphenicol, sulfamethoxazole and 
tetracycline. PFGE analysis with XbaI digestion (Figure 3.5) and PFGE analysis with 
NotI digestion (Figure 3.6) showed that three chicken Salmonella Heidelberg isolates 
(TCD F18, TCD F19 and TCD F20) and two human Salmonella Heidelberg isolates 
(TCD 210902 and TCD 194954) had similar PFGE patterns. Human isolates were 
collected from patients in April and September 2007 from Hospital 174 which is 
located in the Tshwane metropolitan and from an unknown clinic in Gauteng, 
respectively. Three of the chicken Salmonella Heidelberg isolates (TCD F18, TCD 
F19, TCD F20) came from chickens purchased in November 2007 from the Tshwane 
metropolitan (Pretoria) and the Johannesburg metropolitan (Soweto). The current 
results suggest that these chicken and human Salmonella Heidelberg isolates (TCD 
F18, TCD F19, TCD F20, TCD 210902 and TCD 194954) were highly related based 
on our criteria for the determination of significant similarity between human and 
chicken isolates (See section 3.2.7). Chickens contaminated with this clone of 
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Salmonella Heidelberg may have been a food vehicle for human salmonellosis in 
Gauteng since April 2007 through to November 2007. Results shown in the current 
study are typical of those results previously reported in other studies which show a 
link between human and poultry Salmonella Heidelberg isolates (Berrang et al., 
2006; Chittick et al., 2006; Andrysiak et al., 2008). Berrang et al., (2006) showed in 
their study that retail poultry is a common vehicle for spreading antibiotic resistant 
Salmonella Heidelberg to humans throughout Italy. Another study carried out in 
Canada by Andrysiak et al., (2008) showed that Salmonella Heidelberg was rarely 
isolated from other food sources such as pigs and cows; however a large number of 
Salmonella Heidelberg isolates were recovered from retail chickens and were 
implicated as food vehicles in human illness. Chittick and colleagues (Chittick et al., 
2006) showed in their study that poultry and egg-related food products were common 
food vehicles for Salmonella Heidelberg causing several outbreaks of human 
salmonellosis in the USA since 1973 through to 2001.  
 
3.3.5 Salmonella Hadar  
Salmonella Hadar was one of the least frequently isolated serotypes (11%; 5/47) from 
chicken meat (Figure 3.7 and Figure 3.8). These chicken isolates were isolated from 
chicken meat which was purchased from two different areas in the Tshwane 
metropolitan (Pretoria). All the chicken isolates were resistant to tetracycline. PFGE 
analysis with XbaI digestion (Figure 3.7) and PFGE analysis with NotI digestion 
(Figure 3.8) showed that four chicken Salmonella Hadar isolates (TCD F13, TCD 
F14, TCD F15 and TCD F16) and one human Salmonella Hadar isolate (TCD 
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193687) had similar PFGE patterns. The human isolate was received in April 2007 
from Hospital 46 which is located in the Ekurhuleni metropolitan. All four chicken 
specimens were purchased in November 2007 from two different areas in the 
Tshwane metropolitan (Pretoria). Our data suggest that the four chicken isolates 
(TCD F13, TCD F14, TCD F15, TCD F16) and one human Salmonella Hadar isolate 
(TCD 193687) are related based on our criteria for the determination of significant 
similarity between human and chicken isolates (See section 3.2.7). This strain of 
Salmonella Hadar may have been circulating in chickens from April 2007 to 
November 2007. Chicken flocks contaminated with Salmonella Hadar in the USA, 
were a major cause of human salmonellosis in 1988 (Sarwari et al., 2001). A decrease 
in Salmonella Hadar recovered from broiler chickens during the time period of 1990 
to 1995 correlated with the decrease in Salmonella Hadar isolates recovered from 
humans in the USA. These results further suggested that consumption of broiler 
chickens contaminated with Salmonella Hadar may have been responsible for the 
majority of the human Salmonella outbreaks which occurred during this time period 
(Sarwari et al., 2001). Previous studies were also able to show an epidemiological 
link between poultry and human Salmonella Hadar isolates using molecular 
techniques and hypothesized that poultry contaminated with Salmonella Hadar may 
have been a primary food vehicle for human salmonellosis in Spain in 1998 
(Cruchaga et al., 2001) and 2005 (Giannatale et al., 2008) and in most European 
countries from 2000 to 2001 (Giannatale et al., 2008). Results in our study are typical 
of those reported in the above mentioned studies (Cruchaga et al., 2001; Sarwari et 
al., 2001; Giannatale et al., 2008). 
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3.3.6 Salmonella Typhimurium 
Salmonella Typhimurium was one of the least frequently isolated serotypes (11%; 
5/47) from chicken meat (Table 3.1). Chicken Salmonella Typhimurium isolates were 
isolated from chickens purchased from various regions in the Johannesburg 
metropolitan (Soweto) and the Ekurhuleni metropolitan (Tembisa). Two of the 
isolates were resistant to sulfamethoxazole and tetracycline, two were only resistant 
to sulfamethoxazole and the remaining isolate was susceptible to all six (ACSSuTNa) 
antibiotics.  
 
PFGE analysis with XbaI digestion showed that two (TCD F3 and TCD F22) of the 
five chicken Salmonella Typhimurium isolates were not related to any human 
Salmonella Typhimurium isolate (Data not shown). Conversely, PFGE analysis with 
XbaI digestion showed that one of the five chicken isolates (TCD F23) was a 100% 
identical in PFGE profile to eight human Salmonella Typhimurium isolates (Data not 
shown). MLVA separated these eight human Salmonella Typhimurium isolates and 
one chicken Salmonella Typhimurium isolate into eight distinct MLVA types (10, 14, 
21, 22, 23, 24, 25 and 26) (Figure 3.9). MLVA showed that chicken Salmonella 
Typhimurium isolate TCD F23 is different from all eight human Salmonella 
Typhimurium isolates at two or more loci. Therefore the chicken isolate was not 
related to any human isolate, as defined by our criteria for the determination of 
significant similarity between human and chicken isolates (See section 3.2.7).  
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For the remaining two chicken isolates (TCD F21 and TCD F34), their PFGE profiles 
were a 100% identical to the PFGE profiles of ten human isolates (Data not shown). 
MLVA was performed on all of the above isolates. MLVA separated these 12 isolates 
into four distinct MLVA types (14, 15, 20 and 27) (Figure 3.10). Two chicken 
Salmonella Typhimurium isolates (TCD F21 and TCD F34) and one human 
Salmonella Typhimurium isolate (TCD 226213) showed an identical MLVA type 20 
(160-248-314-370-525). Chicken isolate TCD F21 was isolated from a chicken 
specimen purchased in February 2008 from the Ekurhuleni metropolitan (Tembisa) 
and chicken isolate TCD F34 was isolated from a chicken specimen purchased in 
April 2008 from the Johannesburg metropolitan (Soweto). The human isolate TCD 
226213 was received in October 2007 from Hospital 49 which is located in the 
Tshwane metropolitan. These results suggest that the human and chicken Salmonella 
Typhimurium isolates are related and that this strain of Salmonella Typhimurium 
may have been circulating in chickens from October 2007 to April 2008. Previous 
studies performed in the USA (Wedel et al., 2005), in the UK (Harnett et al., 1998), 
in Canada (Zaidi et al., 2007) and in Australia (Heuzenroeder et al., 2004) have 
showed a link between human and poultry Salmonella Typhimurium isolates using 
molecular techniques and have implicated poultry as being a potential reservoir for 
human salmonellosis caused by Salmonella Typhimurium. 
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Figure 3.1 Dendrogram analysis of XbaI-digested DNA from 16 food Salmonella Infantis isolates and 6 human 
Salmonella Infantis isolates separated by PFGE. Lanes 1: ID no, identification number. Lanes 5-10: (Former 
mentioned antibiotics): A, Ampicillin; C, Chloramphenicol; S, Streptomycin; Su, Sulfamethoxazole; T, 
Tetracycline; Na, Nalidixic acid; -, susceptible 
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Figure 3.2 Dendrogram analysis of NotI-digested DNA from 16 food Salmonella Infantis isolates and 6 human Salmonella 
Infantis isolates separated by PFGE. Lanes 1: ID no, identification number. Lanes 5-10: A, Ampicillin; C, Chloramphenicol; S, 
Streptomycin; Su, Sulfamethoxazole; T, Tetracycline; Na, Nalidixic acid; -, susceptible 
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Figure 3.3 Dendrogram analysis of XbaI-digested DNA from 5 food Salmonella Enteritidis isolates and 35 human 
Salmonella Enteritidis isolates separated by PFGE. Lanes 1: ID no, identification number. Lanes 5-10: A, 
Ampicillin; C, Chloramphenicol; S, Streptomycin; Su, Sulfamethoxazole; T, Tetracycline; Na, Nalidixic acid; -, 
susceptible 
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Figure 3.4 Dendrogram analysis of NotI-digested DNA from 5 food Salmonella Enteritidis isolates and 35 human 
Salmonella Enteritidis isolates separated by PFGE. Lanes 1: ID no, identification number. Lanes 5-10: A, 
Ampicillin; C, Chloramphenicol; S, Streptomycin; Su, Sulfamethoxazole; T, Tetracycline; Na, Nalidixic acid; -, 
susceptible. 
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Figure 3.5 Dendrogram analysis of XbaI-digested DNA from 16 food Salmonella Heidelberg isolates and 3 human 
Salmonella Heidelberg isolates separated by PFGE. Lanes 1: ID no, identification number. Lanes 5-10: A, 
Ampicillin; C, Chloramphenicol; S, Streptomycin; Su, Sulfamethoxazole; T, Tetracycline; Na, Nalidixic acid; -, 
susceptible 
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Figure 3.6 Dendrogram analysis of NotI-digested DNA from 16 food Salmonella Heidelberg isolates and 3 human 
Salmonella Heidelberg isolates separated by PFGE. Lanes 1: ID no, identification number. Lanes 5-10: A, 
Ampicillin; C, Chloramphenicol; S, Streptomycin; Su, Sulfamethoxazole; T, Tetracycline; Na, Nalidixic acid; -, 
susceptible 
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Figure 3.7 Dendrogram analysis of XbaI-digested DNA from 5 food Salmonella Hadar isolates and 11 human 
Salmonella Hadar isolates separated by PFGE. Lanes 1: ID no, identification number. Lanes 5-10: A, Ampicillin; C, 
Chloramphenicol; S, Streptomycin; Su, Sulfamethoxazole; T, Tetracycline; Na, Nalidixic acid; -, susceptible 
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Figure 3.8 Dendrogram analysis of NotI-digested DNA from 5 food Salmonella Hadar isolates and 11 human 
Salmonella Hadar isolates separated by PFGE. Lanes 1: ID no, identification number. Lanes 5-10: A, Ampicillin; C, 
Chloramphenicol; S, Streptomycin; Su, Sulfamethoxazole; T, Tetracycline; Na, Nalidixic acid; -, susceptible 
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Figure 3.9 Dendrogram analysis of multiple-locus variable-number tandem-repeats (MLVA) of 8 human 
Salmonella Typhimurium isolates and 1 chicken Salmonella Typhimurium isolate. Lanes 1-5: MLVA profile in the 
order: STTR9-STTR5-STTR6-STTR10pl-STTR3. Lanes 6: ID no, identification number. Lanes 9-14: Na, Nalidixic 
acid; A, Ampicillin; Su, Sulfamethoxazole, C, Chloramphenicol; T, Tetracycline; S, Streptomycin; -, susceptible 
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Figure 3.10 Dendrogram analysis of multiple-locus variable-number tandem-repeats (MLVA) of 10 human 
Salmonella Typhimurium isolates and 2 chicken Salmonella Typhimurium isolate. Lanes 1-5: MLVA profile in the 
order: STTR9-STTR5-STTR6-STTR10pl-STTR3. Lanes 6: ID no, identification number. Lanes 9-14: Na, Nalidixic 
acid; A, Ampicillin; Su, Sulfamethoxazole, C, Chloramphenicol; T, Tetracycline; S, Streptomycin; -, susceptible 
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  Table 3.1 Characteristics of 5 Salmonella Typhimurium strains isolated from chicken meat 
Identification 
number 
Collection 
date 
Area  in Gauteng Antibiotic 
resistance profilea 
Related to any 
human isolates 
(PFGE 
analysis)  
Related to any 
human isolate  
(MLVA) 
TCD F3 16/10/2007 Inhlazane railway 
station, Soweto 
susceptible  No Not done 
TCD F22 08/02/2008 Koti Street, Moteong, 
Tembisa  
SuT No Not done 
TCD F23 08/02/2008 Maphunwe, Teonong, 
Tembisa 
Su Yes  No 
TCD F21 08/02/2008 Moteone, Moteong, 
Tembisa  
SuT Yes Yes 
TCD F34 11/04/2008 Thanda Bantu, Soweto Su Yes  Yes 
 
 a
 Su, Sulfamethoxazole; T, Tetracycline 
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CHAPTER 4  
 
Conclusions 
4.1 Molecular epidemiology of invasive isolates of Salmonella enterica serotype 
Typhimurium in Gauteng, South Africa, 2006-2008 
The current study describes the epidemiology of invasive Salmonella Typhimurium 
isolates in the Gauteng Province of South Africa from January 2006 through to May 
2008. The bacteria demonstrated an extensive genetic diversity as shown by PFGE 
analysis which was able to segregate 671 isolates into 38 clusters. MLVA was useful 
in distinguishing 21 invasive Salmonella Typhimurium isolates (that shared an 
indistinguishable PFGE pattern) into 11 distinct MLVA types. PFGE was useful for 
subtyping a large number of isolates and provided an overview of clonal relatedness 
between Salmonella Typhimurium isolates in the current study. Conversely, apart 
from PFGE analysis being a highly discriminatory method for the subtyping of 
salmonellae, there were a few potential drawbacks of this method. These limitations 
included the generation of ambiguous results due to gel variation and difficulty 
experienced during comparison of DNA fingerprint patterns as a result of differing 
gel quality and the subjective nature of band identification in a PFGE pattern. MLVA 
in comparison to PFGE analysis was a more discriminative subtyping method which 
was faster and data generated by MLVA was unambiguous, easier to analyze and 
interpret.  
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Most isolates showed resistance to multiple antibiotics. Most isolates were from 
patients aged between 15 and 64 years, while patients were mostly HIV-positive. The 
predominance of certain clusters (clusters 3, 5 and 11) within different hospitals in 
the Gauteng Province supports the premise that either patients or staff may have 
moved between hospitals over the period preceding or during the study. The 
occurrence of certain clusters over a prolonged period of time is cause for serious 
concern: it suggests that appropriate infection control measures have been lacking in 
those hospitals for extended periods or are only intermittently followed. In Gauteng, 
South Africa, invasive Salmonella Typhimurium remains an important opportunistic 
infection particularly associated with HIV-positive patients and is associated with 
nosocomial transmission. It is therefore necessary to improve primary antiretroviral 
treatment and subsequent prophylaxis for HIV-infected patients as well as the 
prevention and treatment of HIV related diseases which include salmonellosis. In 
addition, the current study necessitates for re-evaluation of infection-control 
procedures practiced by hospital staff in the Gauteng Province as well as the 
implementation of appropriate changes and conducting of further surveillance studies 
to prevent future nosocomial outbreaks caused by Salmonella Typhimurium in 
Gauteng. 
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4.2 Characterization of Salmonella isolates from chicken meat in Gauteng, South 
Africa, 2007-2008 
The current study describes the characterization of salmonellae isolated from chicken 
meat in Gauteng, South Africa for January 2007 through to May 2008.  PFGE 
analysis using restriction enzymes XbaI and NotI, suggest that Salmonella Infantis 
and Salmonella Enteritidis isolates recovered from humans are unrelated to chicken 
isolates. Conversely, PFGE analysis using the above mentioned restriction enzymes 
suggests that a strong correlation exists between some strains of human Salmonella 
Heidelberg and Salmonella Hadar isolates with those isolates sourced from chickens. 
Furthermore, PFGE analysis using restriction enzyme XbaI and MLVA suggests a 
strong correlation between some human and chicken Salmonella Typhimurium 
strains. MLVA was useful in distinguishing human and chicken Salmonella 
Typhimurium isolates that shared a common PFGE pattern. It is advisable that PFGE 
analysis be applied with a secondary genotypic method for obtaining more 
discriminatory results for future surveillance and control of salmonellosis in both 
humans and chickens in Gauteng, South Africa. 
 
There were two potential limitations to the current study which include the fact that 
chicken samples were purchased from various regions in Gauteng from September 
2007 through to April 2008 and therefore these results do not reflect a true number of 
Salmonella serotypes isolated from chicken meat during this time period. The other 
limitation was that no epidemiological investigations were conducted to substantiate 
an epidemiological link between human salmonellosis and foodborne salmonellae or 
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to estimate the contribution of chicken meat to human salmonellosis in Gauteng. 
Although the work conducted in the current study could not confirm that there is a 
link between foodborne salmonellae and human salmonellosis, it does show that 
Salmonella strains with comparable molecular profiles circulate in the animal and 
human communities, supporting the suggestion of either animal-to-human 
transmission or possibly human-to-animal transmission. Furthermore, foodborne 
diseases are historically not fully investigated in South Africa. The current study 
indicates that further investigation and improvement of the epidemiological 
techniques linking human infection and bacterial contamination of foodstuffs is 
warranted to confirm this theory.  
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APPENDICES 
 
Appendices 
Appendix A 
Determining the O antigen group of a Salmonella species 
• A single colony is inoculated onto a tryptose slope (Diagnostics Media 
Products) and incubated at 37°C overnight for 18 to 24 hours.  
• The next day sterile normal saline (Diagnostics Media Products) is added to the 
tryptose slope and homogenized by vortexing.  
• A loopful of this bacterial suspension is placed on a clean glass slide and 
examined for auto-agglutination. 
• If auto-agglutination occurs then some of the Salmonella cells must be 
resuspended in saline and boiled for 20 to 30 minutes after which this 
suspension should be allowed to cool. 
• Thereafter, serotyping should be repeated. 
•  If no agglutination occurs then add one drop of O polyvalent anti-sera (Statens 
Serum Institut and BioMérieux) to the bacterial suspension and mix by tilting 
the glass slide back and forth and observe for agglutination. 
• If agglutination occurs in O polyvalent anti-sera then the bacteria are further 
tested with the appropriate O monovalent anti-sera (Statens Serum Institut and 
BioMérieux). 
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Determining the H antigen group of a Salmonella species 
• A loopful of bacteria from the tryptose slope is inoculated onto the centre of a 
swarm agar plate (Diagnostics Media Products) which is then incubated at 37°C 
in an upright position for 18 to 24 hours.  
• The next day a loopful of bacteria are picked up from the edge of bacterial 
growth on the swarm agar plate and placed on a clean glass slide, to which one 
drop of H polyvalent anti-sera is added (Statens Serum Institut and 
BioMérieux).  
• Mix by tilting the glass slide back and forth to observe for agglutination. 
• If agglutination occurs in H polyvalent anti-sera then the bacteria are further 
tested with the appropriate H monovalent anti-sera (Statens Serum Institut and 
BioMérieux). 
• If agglutination occurs in H polyvalent anti-sera but no agglutination occurs in 
H monovalent anti-sera then it can be concluded that the Salmonella organism 
being tested contains more than one H phase. 
• Swarm agar is autoclaved and cooled. 
• A drop of the known H monovalent anti-sera is added to some cooled swarm 
agar in a petri-dish (Diagnostics Media Products) and mixed together by 
swirling the mixture in an “S” shape. This is done to block the known H-phase 
and allows the expression of the other H phase or H phases. 
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• The swarm agar mixture is then allowed to solidify. Once the gel is set, a 
loopful of bacteria from the tryptose slope is added to the centre of the swarm 
agar plate. 
• The plate is then incubated at 37°C in an upright position overnight for 18 to 24 
hours.  
• Serotyping should be performed as described above. 
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Appendix B 
Etests 
Preparing an inoculum of Salmonella bacteria  
• Subculture isolates on 5% blood agar plates (Diagnostics Media Products) and 
incubate the plates overnight at 37°C for 18 to 24 hours. 
• The next day, pick three to five colonies from the incubated blood agar plate 
and resuspend in sterile saline (Diagnostics Media Products). 
• The density of the culture should be adjusted to the turbidity reading that equals 
to the reading obtained by a 0.5 McFarland standard (Diagnostics Media 
Products).  
 
Inoculating agar plates 
• Dip a cotton wool applicator into the inoculum and remove excess fluid from 
cotton wool applicator. 
• Mueller Hinton agar plates (Diagnostics Media Products) must be left to reach 
room temperature and must not have any moisture on agar surface before use.  
• Streak the Mueller Hinton agar plates three times at 60° with the cotton wool 
applicator (containing the inoculum) by rotating the agar plate with the use of 
an AB Biodisk disk rotator (AB Biodisk). 
• Leave the agar plates aside for ten to 15 minutes to allow for moisture to be 
absorbed. 
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• Use forceps to place Etest strips (AB Biodisk) on the surface of inoculated 
Mueller Hinton agar plates. 
• Incubate inoculated plates at 37 °C for 16 to 20 hours. 
• Breakpoints were read accordingly (Table 2.1). 
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Appendix C 
Reagents and buffers  
• Lysis buffer 
  0.5 M EDTA (Sigma-Aldrich, Inc.), pH8  
  1% N-lauroylsarcosine sodium salt (Sigma-Aldrich, Inc.) 
0.1 mg/ml proteinase-K (Roche Diagnostics GmbH) 
 
• Suspension buffer 
100 mM Tris (Merck Chemical Ltd., Nottingham, England and Wales) 
100 mM EDTA (Sigma-Alrich, Inc.) 
pH 8 
 
• Proteinase-K 
10 mg proteinase-K (Roche Diagnostics Gmbh) 
1 ml of TE buffer  
 
• 10% SDS 
10 g sodium dodecyl sulphate (Merck Chemical Ltd.) 
100 ml deionized water 
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• 1% agarose gel (plugs) 
0.2 g agarose (SeaKem® Gold Agarose) 
20 ml TE buffer  
Boil to dissolve agarose, hold on a heating block set at 55°C 
  
• 1% agarose gel  
  1.5 g agarose (SeaKem® Gold Agarose) 
  150 ml 0.5 x TBE buffer 
Boil to dissolve agarose, cool slightly and pour the gel into the agarose gel 
casting unit. 
 
• 0.5x TBE buffer  
50 ml of 10x TBE buffer  
  950 ml of deionized water 
 
• Ethidium bromide staining solution 
250 ml of 0.5x TBE buffer (Merck Chemical Ltd.). 
  25 µl of 10 mg/ml ethidium bromide (Merck Chemical Ltd). 
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• TE buffer 
10 mM Tris (Merck Chemical Ltd.) 
1 mM EDTA (Sigma-Alrich, Inc.) 
pH8 
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Appendix D 
Isolation of salmonellae from chicken meat 
Preenrichment 
• Twenty-five grams of chicken meat was weighed out and placed in a sterile 
plastic bag.  
• A small volume of sterile peptone water (Oxoid, Ltd., Basingstoke, Hampshire, 
England) was taken from a bottle containing 225 ml of sterile peptone water 
and added to the weighed test sample. 
• The mixture was then homogenized for 30 seconds using a stomacher (Labotec, 
Italy) and then poured into the remaining buffered peptone water to make up a 
1:10 dilution suspension preparation and thereafter it was incubated at 36°C 
for 24 hours. 
 
Enrichment  
• One milliliter of the incubated peptone water was added to 10 ml of SC broth 
(Diagnostics Media Products). 
• One hundred microlitres of the incubated peptone water and 100 µl of 2 mg/ml 
of novobiocin stock (Sigma-Aldrich® Chemical Co., St. Louis, Missouri, 
USA) were added to RV broth (Diagnostics Media Products). 
• SC broth and RV broth were then incubated for 24 hours at 36°C and 42°C, 
respectively. 
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• Thereafter a loopful of culture from SC broth and RV broth each were 
inoculated on XLD (Diagnostics Media Products) and mannitol lysine crystal 
violet brilliant green (MLCB) agar plates (Diagnostics Media Products).  
• XLD and MLCB agar plates were incubated at 36°C for 24 hours.  
 
Biochemical identification 
• All presumptive Salmonella colonies that were oxidase negative were 
inoculated into Singer’s broth and incubated at 36°C for four to five hours. 
• If the singer’s broth turned a green or yellow colour, the isolate was 
further tested using conventional stool sugars (Diagnostics Media 
Products). 
 
Conventional stool sugars 
• Organisms were identified as Salmonella species if their biochemical reactivity 
(when subjected to a series of biochemical tests) correlated with the 
biochemical reactions shown in Table 1.1.  
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